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Abstract 
Chronic wounds are a significant problem in Australia. The healthcare-related costs of chronic 
wounds in Australia are considerable, equivalent to more than AUD $3.5 billion, approximately 2% of 
national health care expenditure. Chronic wounds can also have a significant negative impact on the 
health-related quality of life of affected individuals. 
Studies have demonstrated that evidence-based care for chronic wounds improves clinical 
outcomes. Decision analytical modelling is important in confirming and applying these findings in the 
Australian context. Epidemiological and clinical data on chronic wounds are required to populate 
decision analytical models. Although epidemiological and clinical data on chronic wounds in Australia 
is available, this has yet to be systematically summarised. 
To address these omissions and clarify the state of the existing evidence, we conducted a systematic 
review of the literature on key epidemiological and clinical parameters of chronic wounds in 
Australia. A total of 90 studies were selected for inclusion. This paper presents a synthesis of the 
evidence on the prevalence and incidence of chronic wounds in Australia, as well as rates of 
infection, hospitalisation, amputation, healing and recurrence. 
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Key Messages 
 chronic wounds are a significant problem in Australia
 although epidemiological and clinical data are available on chronic wounds in Australia, these data 
have yet to be systematically summarised 
 this systematic review identified 90 papers of the prevalence and incidence of chronic wounds in
Australia, as well as rates of infection, hospitalisation, amputation, healing and recurrence 
 this summary of the evidence is important in populating decision analytical models to inform
the best-practice evidence-based management of chronic wounds 
1. 
Chronic Wounds in Australia:  A Systematic Review of Key Epidemiological and Clinical Parameters 
Introduction 
Chronic wounds are defined as wounds which have failed to heal, or to reach anatomic and 
functional integrity1, 2. There are four categories of chronic wounds, each with differing aetiologies: 
arterial ulcers (AUs), diabetic foot ulcers (DFUs), venous leg ulcers (VLUs) and pressure injuries (PIs). 
All categories are a significant problem in Australia. The costs of chronic wounds in Australia are 
considerable, equivalent to more than AUD $3.5 billion, approximately 2% of national health care 
expenditure3. Chronic wounds can also have a major negative impact on the health-related quality 
of life (HRQoL) of affected individuals.4-8 
Studies have demonstrated that evidence-based care for chronic wounds improves clinical 
outcomes9, 10 and is cost-effective11-14. However, economic models have been complicated by 
problems with input data. Decision analytical modelling is an approach for economic evaluation that 
ideally uses evidence from randomised controlled trials and other high quality sources.15 The 
findings should provide evidence to support or reject a practice change against the criterion of value 
for money.16 Epidemiological and clinical data on chronic wounds are required to populate decision 
analytical models about the cost-effectiveness of alternate models of care for chronic wounds.17 The 
identification and synthesis of evidence to populate decision analytical models should emerge from 
a systematic review of the literature.18
Although epidemiological and clinical data on chronic wounds in Australia – including on prevalence 
and incidence, as well as rates of infection, hospitalisation, amputation, healing, and recurrence –
are available, these data have yet to be summarised in a reproducible review. In current economic
evaluations of evidence-based care for chronic wounds in Australia, values for these parameters 
originate from sources of varying quality, from small quasi-experimental studies to expert opinions.
In many cases, key values are derived from studies published in other countries, and from older 
studies which lack relevance to the current health context.  
To address this and clarify the state of the existing evidence, we conducted a systematic review of 
the literature on key epidemiological and clinical parameters of chronic wounds in Australia. Our 
aims were: to identify sources of primary data on the key epidemiological and clinical parameters 
for chronic wounds in Australia and to identify the knowledge gaps in the evidence which need to 
be addressed. Apart from informing economic modelling, such an integrated summary will have 
both clinical and public health applications. To the best of our knowledge, this review is the first to 
summarise the evidence on key clinical and epidemiological parameters relating to chronic wounds 
in Australia.  
Methods 
The review was conducted according to the guidelines recommended by the Preferred Reporting 
Items for Systematic Reviews and Meta-Analyses (PRISMA) statement19 (Supporting Information 
Appendix S1).
2. 
Search strategy 
Searches were conducted on the electronic databases CINAHL, Cochrane Library, EMBASE, 
PubMed and Scopus, up to May 2, 2017. Information on the search strings used is available in the
review protocol (Appendix S2). In addition to the database searches, other sources were identified
by searching official websites (such as the Australian Bureau of Statistics [ABS] and Australian 
Institute of Health and Welfare [AIHW]) and contacting various experts in the field. The reference 
lists of selected studies were screened for other relevant studies. Additional studies and doctoral 
theses were also identified through direct contact with authors. 
Inclusion and exclusion criteria: 
Criteria for inclusion and exclusion were defined prior to conducting the searches (Appendix S2).
Sources were only included in the review if they were published, and if they reported primary data,
and if they related to any chronic wound type(s) (AU, DFU, PI, VLU), and if they measured any of the
outcome(s) of interest (prevalence, incidence, rates of infection, hospitalisation, amputation, 
healing and/or recurrence) and if they were conducted in Australia. Studies reporting wound types
discretely and in combination were considered for inclusion. Studies conducted using routinely-
collected health data as well as epidemiological studies on chronic wounds were considered for 
inclusion. Sources were limited by language (English). For relevancy in reporting, sources were also 
limited by date (January 1, 1990 to May 2, 2017 inclusive).
Screening 
The sources retrieved were screened by title and abstract; those that appeared to meet the
inclusion criteria were then retrieved and read in full-text. Two researchers (L.M. and S.R.)
independently assessed the sources for eligibility. Where disagreements occurred, reviewers 
discussed these with the study’s primary investigator (R.P.) to reach consensus.
Quality assessment  
The quality of the selected sources was assessed using a tool designed to assess risk of bias in 
population-based prevalence studies20, and modified for our study (Appendix S2).
Data extraction 
A data extraction tool was developed by the research team to extract 10 data items about key 
features of the studies – including publication details, setting, design, sample, instrument and 
parameters of interest (Appendix S3). Data was extracted collaboratively by two researchers (L.M.
and S.R.).
Two researchers (L.M. and S.R.) independently evaluated each of the sources for quality
(Appendix S4). Again, disagreements were resolved via discussions with a senior team member
(R.P.) until consensus was reached. The total quality score for each study was the sum of the scores 
for each individual assessment item. This was converted to a proportional quality score (the total 
quality score divided by the maximum score possible expressed as a percentage). A source received 
an unfavourable rating on any quality evaluation question where there was insufficient information 
reported within it to answer the evaluation question with confidence.20 
3. 
Results
Out of 1274 records screened, 90 studies met the criteria for inclusion (Figure 1). 
INSERT FIGURE 1 
A summary of study characteristics for each of the 90 studies selected for inclusion is presented in 
Appendix S3. The studies were published from 199121 to 201622-27 inclusive. Cohorts from all six 
states and two territories in Australia were included in at least one study. The studies were a mix of 
retrospective and prospective designs, undertaken in acute healthcare facilities (e.g. hospitals), 
non-acute healthcare facilities (e.g. residential aged care settings) and/or community settings. Most 
studies were published in peer-reviewed journals, though a number of government reports and 
two Doctor of Philosophy theses were also included. The studies each reported on one or more 
parameters of interest, in relation to one or more chronic wound types.  
Other key features of the studies are presented in Table 1. 
INSERT TABLE 1 
Prevalence 
Arterial ulcers (AUs) 
All of the studies on AUs reported prevalence. Most measured prevalence in people with lower-
extremity ulcers specifically.9, 28-35 Prevalence of AUs as a primary cause of ulceration in this 
population ranged from 3.0%32 to 19.0%.33 Other studies measured prevalence in people with all 
types of wounds (including chronic, surgical and traumatic wounds).36, 37 Prevalence of AUs as a 
primary cause of ulceration in this population ranged from 1.0% 37 to 10.9%.36 One study found 
that 74.5% of people with foot ulcers specifically had associated arterial disease.28
Diabetic foot ulcers (DFUs) 
Many of the papers on DFUs reported prevalence. Some measured prevalence in people with lower 
extremity ulcers specifically.9, 28, 32, 34, 35 Prevalence of DFUs as a primary cause of ulceration in this 
population ranged from 2.5%28 to 12.0%.35 One paper measured the prevalence of DFUs in people 
with all types of wounds (including chronic, surgical and traumatic wounds) and reported this to be 
2.6%.37
A number of studies reported on the prevalence of DFUs in all people with diabetes38-40; this 
ranged from 1.2%38 to 2.5%.40 Prevalence of DFUs was reported at 1.0% in the first year of 
diabetes diagnosis.40 One study found that, of people with diabetes-related foot complications, 
32.6% had a DFU specifically.41 Other studies reported diabetes mellitus was found in 48.5%28 to 
85.0%42 of people with foot ulcers. 
Venous leg ulcers (VLUs) 
4. 
Most of the studies on VLUs reported prevalence. Some measured prevalence in people with lower- 
extremity ulcers specifically.9, 28-35, 43 Prevalence of VLUs as a primary cause of ulceration in this  
population ranged from 1.0%35 to 70.5%.34 Two studies measured prevalence in people with all 
types of wounds (including chronic, surgical and traumatic wounds); the prevalence of VLUs as a 
primary cause of ulceration in this population was reported to be between 3.1%37 and 53.1%.36 In a 
large, population-based study in Perth, prevalence in persons ≥60 years was 3.3 per 1000.20
Pressure injuries (PIs) 
Most of the studies on PIs reported prevalence. Some measured the prevalence of PIs in acute 
healthcare facilities (eg, hospitals).33, 35, 44-68 Prevalence ranged from 0.2%49 to 29.6%59 in hospital 
settings. Other papers reported prevalence of PIs in specific populations in acute healthcare settings 
– including in medical patients: 3.8%,68 in surgical patients: 4.1%,68 in people undergoing coronary
artery bypass graft: 2.9%,69 in people undergoing orthopaedic hip replacement: 3.3,69 in people 
with dementia: 4.0%,68 in people receiving intensive care: 11.5%24 to 50.0%,70 and in long-stay 
patients (≥ 91 days): 25.0%.67
Some papers measured the prevalence of PIs in non-acute healthcare facilities (e.g. residential 
aged care settings).26, 71-73 Prevalence ranged from 0.03%73 to 25.9%.72
Some larger studies involved a mix of acute and non-acute health care facilities26, 74; these measured 
the prevalence of PIs to be between 9.1%26 and 12.5%.74 In people in acute and non-acute health 
care facilities who were classified as malnourished, the prevalence of PIs was measured at 31.5%.75 
Many of the studies which measured PI prevalence in healthcare facilities reported on rates of 
healthcare- (versus community-) acquired PIs.24, 26, 47, 50, 53, 54, 60, 64, 66, 76 One study found the 
prevalence of PIs on admission to hospital to be 4.9%, versus prevalence at discharge of 5.7%.77 
Another study measured the prevalence of medical device-related PIs in acute healthcare settings 
specifically to be 6.1%.76
Most of the studies which measured PI prevalence in acute and non-acute healthcare facilities also 
reported on PI staging.24, 26, 37, 44, 45, 47, 51, 53, 55, 58-61, 63, 64, 66, 67, 69, 72-74, 78-82 The majority of PIs in these 
studies were at Stage I (non-blanchable erythema only). In a state-wide sample of acute and non-
acute healthcare settings, the proportion of PIs in Stage I was estimated at 44.0%.26
Some of the studies measured the prevalence of PIs in the community. In studies involving general 
practitioners or community nursing services,26, 80, 81 the prevalence of PIs – as a percentage of total 
presentations – ranged from 7.7%26 to 42.3%.80 One study measured prevalence in people with 
lower extremity ulcers in the community specifically, 5.0%.43 Other papers reported on prevalence 
in people with wounds generally (including chronic, surgical and traumatic wounds)30, 36, 37; 
prevalence of PIs as a primary cause of ulceration in this population ranged from 6.0%30 
to 11.0%.37 
It is important to acknowledge that some of the health care facilities involved in the above 
studies had PI improvement initiatives in place, whereas others did not. A number of the studies 
reported on declines, often significant, in PI prevalence as a result of such interventions.53, 56, 57, 
59, 60, 65, 70, 71, 75, 79, 83 For these studies, baseline (pre-intervention) PI prevalence is reported 
above.  
5. 
Leg ulcers (LUs) 
Some studies reported prevalence in people presenting to community healthcare services (31, 43, 
84, 85); prevalence was reported at 1.184 to 7.043 per 1000 patient encounters, and at 0.1%31 and 
0.3%85 of all patient encounters. Prevalence was estimated at 5.9 per 1000 in people aged ≥60 
years21, at 0.6% in people aged ≥65 years31, and at 24 per 1000 in people aged ≥75 years.43 Among 
people presenting to a community healthcare service with a wound (including chronic, surgical and 
traumatic wounds), 48.2% had a LU.29 Two studies measured the prevalence of LUs in hospitalised 
patients; prevalence ranged from 2.3%61 to 2.8%.74 One study reported the prevalence of all-cause 
foot ulcers among hospitalised patients; 9.8% of people reported having a previous foot ulcer, and 
6.3% were found to have a current foot ulcer.27 
Incidence 
Arterial ulcers (AUs) 
None of the studies on AUs reported incidence. 
Diabetic foot ulcers (DFUs) 
Some of the papers on DFUs reported incidence. One study reported that 6.3% of people with 
diabetes mellitus developed a new DFU in a three month study period.86 Another study found that 
34.2% of people developed a new DFU in the study period, but this was a short report and the study 
period was not specified.87 Another paper found that 6.3% of people with diabetes mellitus and 
neuropathy developed a DFU, compared with 0.5% of people with diabetes mellitus but without 
neuropathy.88 An Australia-wide retrospective cross-sectional population survey found that 19.6% of 
people with diabetes mellitus had clinical features which placed them ‘at risk’ of developing a DFU89; 
however, this paper did not measure or estimate how many of these people actually developed a 
DFU.  
Venous leg ulcers (VLUs) 
None of the studies on VLUs reported on incidence. 
Pressure injuries (PIs) 
A number of the papers on PIs reported incidence.23, 45, 46, 55, 59, 64, 67, 78, 79, 82, 83, 90, 91 These papers 
measured incidence over a variety of time-periods, from 7 days55 to 12 months.78 Some papers 
reported incidence of PIs in general medical patients in acute healthcare settings (e.g. hospitals)46, 55, 
59, 67, 79, 83, 90; incidence ranged from 6.5% in 7 days (shortest time-period)55 to 16.6% in 6 months 
(longest time-period).83 Other papers reported incidence of PIs in people undergoing various 
surgical procedures23, 45, 82, 91; incidence ranged from 11.1% in 6 weeks (shortest time-period)82 to 
11.8% in 7 months (longest time-period).23 One study reported on incidence of PIs in people in 
intensive care settings, at 30.4% in 12 months.78 
6. 
One study estimated the risk of developing a healthcare-associated PI in a hospital to be between 
9.8% and 12.0%, equating to 7.2 to 7.6 per 1000 bed days.64 
Leg ulcers (LUs)  
None of the studies on LUs reported incidence. 
Infection  
Arterial ulcers (AUs) 
One paper found that 16.7% of the people with AUs showed signs of infection; however, 
this equated to just 1 out of 6 people with AUs included in the study.9  
Diabetic foot ulcers (DFUs) 
Three of the papers on DFUs reported rates of infection9, 41, 92; between 14.6%41 and 49.7%92 of 
DFUs showed clinical sign(s) of infection.  
Venous leg ulcers (VLUs) 
Three of the papers on VLUs reported rates of infection9, 93, 94 In groups receiving standard care or 
baseline cohorts, infection ranged from 5.9%93 to 58.1%.94 
None of the included studies reported rates of infection for PIs and LUs. 
Hospitalisation  
Arterial ulcers (AUs) 
None of the studies on AUs reported rates of hospitalisation. 
Diabetic foot ulcers (DFUs) 
One paper found that an infected DFU was the primary cause of hospitalisation in 79 admissions per 
100 000 person years.95 This study also reported that the median duration of hospital stay once 
admitted with DFU-related complication(s), and particularly infection, was 29.0 days.95 Another 
study measured the incidence of first-ever hospital admission for DFU to be 5.21 per 1000 patient-
years.38 Another study found that 1.8% of people with diabetes mellitus had been hospitalised for 
complications related to a DFU.39 
Venous leg ulcers (VLUs) 
7. 
One study reported that 6.0% of people with VLUs were admitted to hospital, due to failure of 
the wound to heal and / or wound deterioration.32
Pressure injuries (PIs) 
None of the studies on PIs reported rates of hospitalisation; rather, reporting focused on mean 
length of hospital stay. One study found that the mean length of hospital stay for general medical 
and surgical patients who developed a PI was 61.1 days.65 Another reported the mean length of 
hospital stay for general medical and surgical patients who developed a PI was 34.0 days, versus 
25.0 days for people who did not develop a PI.67 Another study measured the hospital stay for 
people undergoing coronary artery bypass graft who developed a PI at 22.4 days, versus 12.7 days 
for patients who did not develop a PI, and for people undergoing an orthopaedic hip replacement 
who developed a PI at 31.2 days, versus 19.7 days for patients who did not develop a PI.69  
Leg ulcers (LUs) 
Two papers on LUs reported rates of hospitalisation; these studies found that between 4.5%34 
and 13.8%32 of people with LUs were admitted to hospital because of complications with their 
wound. 
Amputation 
Arterial ulcers (AUs) 
None of the studies on AUs reported on rates of amputation. 
Diabetic foot ulcers (DFUs) 
A number of the studies on DFU reported on rates of DFU-related amputation.22, 92, 95-98 The studies 
measured rates of ≥1 minor amputation (below the ankle) to range from 2.1%92 to 36.5%,96 and rates 
of ≥1 major amputation (above the ankle) to range from 0.5%92 to 23.0%.96 One study found that in 
people who had one minor amputation for a DFU-related complication, 26.0% also had at least one 
subsequent minor amputation and 18.5% had at least one subsequent major amputation.95  
One study reported that DFU was a significant independent predictor of first-ever lower-extremity 
amputation in people with diabetes mellitus (hazard ratio [95% CI]: 5.56 [1.24-25.01]).97 Another 
found that DFU was the major cause of amputation in 17.2% of all amputations performed in a 
major metropolitan hospital in a two-year period.99 Another study concluded that of the 7.0% of 
people with diabetes mellitus who experienced an amputation (minor or major), 34.0% were the 
direct result of a DFU.98  
Venous leg ulcers (VLUs) 
None of the studies on VLUs reported on rates of amputation. 
8. 
Pressure injuries (PIs) 
None of the included studies on PIs reported on rates of amputation. 
Leg ulcers (LUs) 
One study found that among people with LUs receiving standard care, 13.9%35 received an 
amputation.  
Healing 
Arterial ulcers (AUs) 
Three studies reported on median time to healing for AUs. One study reported 33.3% of AUs healed 
in ≤12 months.36 In another study, median time to healing of AUs was measured at 107.0 days.37 In 
a third study, data about median time to healing was presented graphically and could not be 
quantified.9  
Diabetic foot ulcers (DFUs) 
The studies on DFUs reported healing in a variety of ways. Some measured healing in a given 
period. One study reported 74.8% of DFUs in people receiving standard care healed in ≤28 days.100 
Another found 47.0% of DFUs healed in 12 weeks and 72.0% healed in 20 weeks.41 Three studies 
reported median time-to-healing for DFUs in people receiving standard care,37, 41, 42 ranging from 
6.0 weeks42 to 15.7 weeks.41 In one study, time-to-healing for DFUs was presented graphically and 
could not be quantified.9 
Venous leg ulcers (VLUs) 
The studies on VLUs also reported healing in a variety of ways. Some reported healing in groups 
receiving standard care – at ≤12 weeks,93, 101-103 ranging from 23.5%93 to 45.1%103; at 24 weeks: 
38.5%104; at 6 months: 73.6%32; and at 12 months: 67.7%.36 Some reported healing in groups 
receiving specialist care – at ≤12 weeks,9, 93, 101-103 ranging from 43.6%93 to 73.0%103; and at 24 
weeks: 57.6%.104 In a group receiving specialist care, 96.8% of low-risk patients, and 25.0% of high-
risk patients, healed in 24 weeks.105
Other studies reported healing of VLUs in comparison groups receiving different specialist 
interventions – for example, three-layer versus four-layer compression bandaging (72.0% versus 
84.0% healing in 24 weeks),106 and with different types of dressings, ranging from 58.7% to 86.0% in 
9 months.107 
One study found the median time to healing for VLUs to be 63.9 days.37 In one study, time-to-
healing for VLUs was presented graphically and could not be quantified.9 
9. 
Pressure injuries (PIs) 
The papers on PIs reported healing in a variety of ways. One study found the average time to healing 
of a PI was 57.9 days; average time to healing for Stage I PIs was 45.6 days, Stage II PIs was 56.5 
days, Stage III PIs was 58.9 days and Stage IV PIs was 58.3 days.37 Another study reported that 
among people presenting to a community wound clinic with a PI, 100.0% had healed in ≤12 
months.36 A third study found that with an intensive nutrition intervention, 58.1% of malnourished 
people with a PI healed within the period of their hospital admission, with length of admission 
averaging 14.0 days.25 
Leg ulcers (LUs) 
Studies on LUs reported outcomes related to healing in a variety of ways.  Studies reported that, 
with standard care, between 20.3%31 and 38.8%32 of LUs healed in 3 months, 67.0%32 healed in 6 
months, and 92.6%32 healed in 12 months. Another study reported that in uncomplicated LUs, 
mean time to healing was 4.6 weeks, and in LUs with one or more complications, mean time to 
healing was 23.9 weeks.34 In a control group, mean rate of healing by ulcer area was reported to 
be 6.3% per week.35 The mean duration of LUs prior to healing among the people participating in 
one study was reported to be 9.0 years.31
Recurrence 
Arterial ulcers (AUs) 
None of the studies on AUs reported rates of recurrence. 
Diabetic foot ulcers (DFUs) 
One study found that 3.6% of people who presented to a health care service with a DFU had had 
at least one previous DFU.92 Another study reported a 37.0% rate of recurrence.42 
Venous leg ulcers (VLUs) 
The studies on VLUs defined and measured rates of recurrence in multiple ways. In most studies, 
recurrence was defined as a new ulcer developing after the patient healed, and could be on the 
other leg or other location. Some measured the number of people with a current VLU who 
reported a previous VLU21, 93, 94, 108; this ranged from “half”, assumed to be 50.0%,108 to 81.7%.94 
Other studies measured recurrence after healing within 5 weeks: 23.1%103; at 3 months, ranging 
from 5.6%9 to 36.0%109; at 6 months: 73.5%32; and at 12 months,9, 109 ranging from 16.7%9 to 
20.0%.109 Other studies reported a median time to recurrence, ranging from 11.1 weeks94 to 63.0 
weeks.9
Pressure injuries (PIs) 
None of the studies on PIs reported rates of recurrence. 
10. 
Leg ulcers (LUs) 
One study found that 65.0% of people who presented to a community healthcare service with an 
LU had at least one previous LU.28 
Study Quality and Risk of Bias 
Supplementary Material S4 sets out the quality assessment and scoring results for each of the 
studies selected for inclusion. Overall quality scores ranged from 30% to 90%. Four of the 90 
included studies scored 90%27, 51, 61, 66; we concluded that these studies had relatively high internal 
and external validity and risk of bias was considered minimal in these studies. Twenty-two of the 
studies scored ≤50% in terms of quality; we concluded risk of bias was relatively high for these 
studies, particularly regarding representativeness of the study population, selection bias, non-
response bias and lack of use of an acceptable case definition. The quality of the included studies 
was moderate, with an average quality score of 64%. 
Discussion 
To the best of our knowledge, this is the first review of published studies reporting on the 
prevalence, incidence and rates of infection, hospitalisation, amputation, healing and recurrence of 
chronic wounds in Australia. A total of 90 studies were included.  
A key finding to emerge from this review is that all types of chronic wounds – AUs, DFUs, VLUs and 
PIs – are highly prevalent in Australia. There was a considerable amount of data on prevalence of all 
wound types in a variety of cohorts. However, of the studies selected for inclusion, most were 
published prior to 2010 and not representative of the Australian population. Given population 
ageing and the obesity epidemic, prevalence of chronic wounds has probably increased in recent 
years. Prevalence was reported in specific populations – for example: in people with lower extremity 
ulcers, people presenting to community wound services, people admitted to hospital, and people 
with comorbidities such as diabetes mellitus. None of the studies selected for inclusion gave an 
estimate of the prevalence of chronic wounds in the general Australian population. As a result, it 
remains difficult to estimate the number or people currently affected with chronic wounds in 
Australia.  
It is interesting to compare our findings about the prevalence of chronic wounds in Australia – a key 
parameter for economic modelling – to the international literature. A recent literature review 
involving 69 international studies110 returned the following findings:  
Arterial ulcers (AUs) 
Internationally, the prevalence of AUs in the community was 0.02% to 0.35%110 (compared with our 
finding of 3.0% to 19.0% in people with lower extremity ulcers, and 0.7% to 10.9% in people with 
wounds generally). This review supported our finding of a paucity of evidence on the prevalence 
(and incidence) of arterial ulcers.110
11. 
Diabetic foot ulcers (DFUs)
Internationally, the prevalence of DFUs in acute healthcare facilities (e.g. hospitals) ranged from 
1.2% to 20.4%, and in non-acute healthcare facilities (e.g. residential aged care settings) it 
ranged from 0.02% to 9.0%110 (compared with our finding of 2.5% to 12.0% in people with lower 
extremity ulcers, and 2.6% in people with wounds generally). 
Venous leg ulcers (VLUs) 
Internationally, the prevalence of VLUs in acute healthcare facilities (e.g. hospitals) was 0.05%, in 
non-acute healthcare facilities (e.g. residential aged care settings) it was 2.5%, and in the 
community it ranged from 0.05% to 1.0%110 (compared with our finding of 1.0% to 70.5% in people 
with lower extremity ulcers, and 2.3% to 53.1% in people with all types of wounds). 
Pressure injuries (PIs) 
The prevalence of PIs in acute healthcare facilities (e.g. hospitals) ranged from 1.1% to 26.7%110 
(compared with our finding of 0.2% to 29.6%); in people receiving intensive care it ranged from 
13.1% to 28.7%110 (compared with our finding of 11.5% to 50.0%); and in non-acute healthcare 
facilities (e.g. residential aged care settings) it ranged from 7.6% to 53.2%110 (compared with our 
finding of 0.03% to 25.9%).  
The same problem we encountered with reporting prevalence – noted above, that this was 
population-specific – was also found with incidence. Again, there was a considerable amount of data 
on the incidence of all wound types, in a variety of cohorts; however, incidence was typically 
reported in specific populations (such as those listed above). Aside from one study which gave an 
estimated risk of developing a healthcare associated PI during a hospital admission,64 none of the 
studies reported incidence rates of PIs in the Australian general population. Additionally, incidence 
was measured over a variety of time-frames, making comparison with the international literature 
review described above110 difficult. There were some difficulties with determining the difference 
between incidence and recurrence; in all instances, we used the same terminology as the study 
authors.  
This review also returned important findings in relation to the clinical outcomes of interest – rates of 
infection, hospitalisation, amputation, healing and recurrence. The literature selected for inclusion 
reported highly variable rates of infection for most chronic wound types; this was possibly due to 
problems with the definition and diagnosis of ‘infection’, discussed later. For most chronic wound 
types, rates of hospitalisation were relatively low, however once a person was admitted to hospital 
for complications associated with a chronic wound, or if they developed a chronic wound whilst 
hospitalised (e.g. a PI), their length of stay was likely to be considerable.  
Rates of amputation were relevant mainly to DFUs, and the rates of both minor and major 
amputation for people with this type of chronic wound were high. There was a considerable amount 
of data on rates of healing for all wound types, and again this was highly variable; this was possibly 
due to problems with treatment and confounding factors affecting rates of healing, again discussed 
later. Finally, there were limited data on recurrence, but available data suggests the risk of 
recurrence is high for DFUs and VLUs in particular.  
12. 
Although some data was available on a few parameters for all chronic wound types – AUs, DFUs, 
VLUs and PIs –in the studies selected for inclusion, there was a particularly large amount of data on 
PIs. Indeed, 60% of the studies identified for inclusion (n = 52) reported on PIs. There were a 
moderate number of studies on VLUs (n = 24) and DFUs (n = 23) papers, but a relative paucity of 
data on AUs (n = 11). This is an important finding, considering this review suggests AUs are not 
significantly less prevalent than DFUs and perhaps VLUs, by some measures. The apparent paucity of 
literature on AUs may also be related to the inconsistencies, and lack of clarity, in defining different 
ulcer types – particularly, distinguishing between AUs and VLUs.  
This review also found an absence of data for a number of key clinical outcomes. There was no data 
reported in the studies selected for inclusion on rates of infection in PIs, rates of amputation in AUs, 
VLUs or PIs, and rates of recurrence in AUs and PIs. Of note was the limited data available on rates of 
hospitalisation due to complications for specific types of chronic wounds. This represents an 
important gap in the existing knowledge, and a possible focus for future Australian research.  
As noted, the majority of the studies were small local (single-site) or slightly larger regional (multi-
site) studies. There were only a few state-wide studies, fewer multi-state studies and two nation-
wide studies43, 89 identified. Most studies included small cohorts from specific locations – often, a 
single or small group of healthcare facilities – limiting generalisability. This is particularly 
problematic as the quality assessment indicated the likelihood of non-response bias and selection 
bias in many of the studies was high.  
The few larger studies also had limitations. The state-wide and multi-state studies focused on 
New South Wales26, 43, 65, 68, 71, 72 Queensland,24, 42, 49, 65 South Australia,71, 72 Victoria49, 65, 66, 71, 72, 94 
and Western Australia,40, 61, 65, 71, 72, 74 with the less-populous states and territories of Tasmania, 
the Northern Territory and the Australian Capital Territory nearly entirely overlooked. 
Additionally, two nation-wide studies included had significant limitations. The first did not directly 
measure any of the outcomes of interest for this review, but instead reported on the concept of 
people with diabetes mellitus ‘at risk’ of developing a DFU.89 The second was reported as a 
conference abstract only.42 
Study Limitations 
The findings of this systematic review should be interpreted in light of a number of limitations of our 
review. There were significant problems with how the different chronic wound types (AU, DFU, VLU 
and PI) were defined in the studies. Some used clear definitions of wound types – based on an 
international consensus definition (e.g. those contained in a reliable and valid assessment tool) or 
clear diagnostic criteria – but many did not. This made it difficult to determine the accuracy of 
outcomes reported about a particular wound type. This was especially problematic in the 
retrospective studies, where it was typically difficult to determine how chronic wounds were 
assessed, their aetiology diagnosed and if this was a standardised process for all participants 
included in the study. These studies frequently received low quality scores for this reason. There 
were also problems with the definitions used by the small number of studies which considered ‘leg 
ulcers’ as a group; some of these studies included in their definition of ‘leg ulcers’ other types of 
wounds such as skin tears, burns and malignancies, etc.  Again, for this reason these studies typically 
received relatively low quality scores.  
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Many of the studies used non-standardised definitions for the other key outcomes – in particular, of 
wound infection, but also of hospitalisation, healing and recurrence. This lead to outcomes being 
measured in different ways – for example: hospitalisation may have been measured as rate of 
hospital admission or length of stay. Similarly, recurrence may have been measured as recurrence of 
a known wound, or history of previous chronic wound(s) of the same aetiology as a current wound. 
Non-standardised definitions also resulted in variability in outcomes between studies – for example: 
the two studies reporting on rates of infection in VLUs, which included comparable cohorts and 
involved similar research methods, reported highly discrepant rates of infection: 5.9%93 and 
58.1%.94 Different definitions precluded a meta-analysis, and resulted in difficulties reporting 
results in meaningful ways.  
There were also problems with the way in which healing was measured and reported in many of the 
studies. Some studies compared rates of healing in standard care (control) versus specialist care 
(intervention) groups, but many did not. A large number of studies reported ‘healing’ without 
specifying the treatment(s), if any, used on the wound. This outcome was therefore highly exposed 
to confounding, and difficult to report with accuracy.  
A number of studies on DFUs originally identified for inclusion in the review111-113 were 
subsequently excluded, because they grouped DFUs with other diabetes-related foot complications 
– for example: peripheral neuropathy, peripheral vascular insufficiency, cellulitis, Charcot
arthropathy, or osteomyelitis. When reporting on outcomes such as amputation, it was not possible 
to determine in these studies if amputation was due to a DFU specifically (as per our inclusion 
criteria) or other diabetes-related foot complications more generally, or even a combination of both. 
For this reason, these studies were excluded.  
There were also some limitations with the review process which must be acknowledged. A limited 
number of databases were searched, and it is possible that sources, including grey literature, 
published elsewhere were missed. The data extraction tool was not validated. Although three 
researchers were involved in the assessment of study quality process (L.M., S.R., R.P.), only one 
(L.M.) conducted the final synthesis of the data, and no rigorous inter-rater checks were 
conducted.  
Conclusion and Recommendations 
In this paper we have presented the method and findings of a reproducible literature review 
regarding evidence on important epidemiological parameters of prevalence and incidence, and key 
clinical parameters of rates of infection, hospitalisation, amputation, healing and recurrence of 
chronic wounds in Australia. We show there are large gaps and limitations in the existing evidence. 
The knowledge gaps in some key parameters need to be addressed as a matter of urgency. The 
effective implementation and evaluation of evidence-based wound care depends on the availability 
of reliable and comparable information and as better quality evidence becomes available, future 
economic modelling will be more accurate and reliable. 
We recommend targeted primary research to establish the epidemiological profile of chronic 
wounds in Australia. A nationally representative prevalence survey should be conducted at regular 
intervals and in line with international best practice to identify baseline prevalence and size of the 
problem in Australia. In addition, a national wound registry should be established to provide real 
patient data on clinical wound outcomes, and facilitate comparative effectiveness research to 
identify patients needing advanced treatment. For this to be achieved, a number of barriers to 
collaboration between sectors must be overcome – including establishment costs and jurisdictional 
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funding issues, sensitivities around data sharing, and the challenge of the sustainability of chronic 
wound services.  
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Figure 1: The PRISMA flowchart illustrating study selection 
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Studies included in 
qualitative synthesis 
(n = 90) 
Table 1 
Chronic 
Wound 
Type 
Number 
of Papers 
Scope of Papers States / Territories 
Included 
Range of 
Quality 
Scores 
Arterial 
ulcers 
(AUs) 
11 (9, 28-
37) 
All studies included 
small local (single-site) 
or regional (multi-site) 
populations, in single 
states 
NSW (31); QLD (9, 34); 
TAS (33); VIC (37); WA 
(28-30, 32, 35, 36) 
40% (34, 
36) to
80% (35) 
Diabetic 
foot ulcers 
(DFUs) 
23 (9, 22, 
28, 32, 34, 
35, 37-42, 
86-89, 92, 
95-100) 
Most studies included 
small local (single-site) 
or regional (multi-site) 
populations in single 
states / territories; there 
were two studies which 
included state-wide 
cohorts (40, 42), and 
one which included a 
multi-state cohort (89) 
NSW (88, 92); NT (95, 
96, 98); QLD (9, 22, 34, 
42), VIC (37, 41, 86, 87, 
100); WA (28, 32, 35, 
38-40, 97, 99) 
There was one study 
which included a multi-
state (89) 
30% (87) 
to 80% 
(35, 38, 
39)
Venous 
leg ulcers 
(VLUs) 
24 (9, 21, 
28-37, 43, 
93, 94, 
101-109) 
Most studies included 
small local (single-site) 
or regional (multi-site) 
populations in single 
states; there were also 
studies which included 
state-wide cohorts (94) 
and two studies which 
included a multi-state 
cohort (43, 103) 
NSW (31); QLD (9, 34, 
93, 101, 102, 104-106, 
109); TAS (33); VIC (37, 
94, 108); WA (21, 28-
30, 32, 35, 36, 107) 
There were two studies 
which included a multi-
state cohort (43, 103) 
40% (34, 
36) to
80% (35, 
106) 
Pressure 
injuries 
(PIs) 
52 (23-26, 
30, 33, 35-
37, 43-83, 
90, 91) 
Most studies included 
small local (single-site) 
or regional (multi-site) 
populations in single 
states; there were a 
number which included 
state-wide or multi-state 
cohorts (24, 26, 43, 49, 
61, 66, 68, 74) 
ACT (79); NSW (26, 43, 
51, 53, 55, 68-70); QLD 
(23-25, 44-46, 48, 50, 
52, 57, 73, 75-78, 91); 
SA (59); TAS (33, 62); 
VIC (37, 47, 54, 56, 58, 
63, 66, 83); WA (30, 35, 
36, 60, 61, 64, 67, 74, 
80-82, 90) 
There was one study 
where the location was 
unclear (71) 
There were a number of 
studies which included 
multi-state cohorts (43, 
49, 65, 72) 
40% (36, 
48, 52, 
56, 76, 
91) to
90% (51, 
66)
Leg ulcers 
(LUs) 
(generally, 
without 
dividing these 
into wounds of 
arterial, 
diabetic, 
venous or 
other 
aetiology)
11 (29, 31, 
32, 34, 35, 
42, 43, 61, 
74, 84, 85) 
Most studies included 
small local (single-site) 
or regional (multi-site) 
populations in single 
states; there were three 
studies which included 
state-wide or multi-state 
cohorts (43, 61, 74) 
NSW (31, 43, 85); QLD 
(34, 42); WA (29, 32, 
35, 61, 74, 84) 
40% (34) 
to 90% 
(42, 61) 
Table 1: Overall summary of characteristics of included studies 
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Title 1 Identify the report as a systematic review, meta-analysis, or both. Title 
ABSTRACT 
Structured summary 2 Provide a structured summary including, as applicable: background; objectives; data sources; 
study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; 
results; limitations; conclusions and implications of key findings; systematic review registration 
number. 
Abstract 
INTRODUCTION 
Rationale 3 Describe the rationale for the review in the context of what is already known. Introduction: 
paragraphs 
1, 2, 3, 
Objectives 4 Provide an explicit statement of questions being addressed with reference to participants, 
interventions, comparisons, outcomes, and study design (PICOS). 
Introduction: 
paragraph 4 
METHODS 
Protocol and registration 5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if 
available, provide registration information including registration number. 
Not 
applicable 
Eligibility criteria 6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., 
years considered, language, publication status) used as criteria for eligibility, giving rationale. 
Methods: 
paragraph 3 
and S2 
Information sources 7 Describe all information sources (e.g., databases with dates of coverage, contact with study 
authors to identify additional studies) in the search and date last searched. 
Method: 
paragraph 2 
Search 8 Present full electronic search strategy for at least one database, including any limits used, such 
that it could be repeated. 
Methods: 
paragraphs 
1-7 and S2 
Study selection 9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, 
and, if applicable, included in the meta-analysis). 
Methods: 
paragraphs 
3-7 and S2 
Data collection process 10 Describe method of data extraction from reports (e.g., piloted forms, independently, in 
duplicate) and any processes for obtaining and confirming data from investigators. 
Methods: 
paragraph 6 
and S2 
Data items 11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any 
assumptions and simplifications made. 
Methods: 
paragraph 6 
and S2 
Risk of bias in individual 
studies 
12 Describe methods used for assessing risk of bias of individual studies (including specification of 
whether this was done at the study or outcome level), and how this information is to be used in 
any data synthesis. 
Methods: 
paragraph 5 
and S2 
Summary measures 13 State the principal summary measures (e.g., risk ratio, difference in means). Methods: 
paragraph 3 
and S2 
Synthesis of results 14 Describe the methods of handling data and combining results of studies, if done, including 
measures of consistency (e.g., I2) for each meta-analysis. 
Not 
applicable 
RESULTS 
Study selection 17 Give numbers of studies screened, assessed for eligibility, and included in the review, with 
reasons for exclusions at each stage, ideally with a flow diagram. 
Results: 
paragraph 1 
and Figure 
1 
Study characteristics 18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, 
follow-up period) and provide the citations. 
S3 
Risk of bias across 
studies 
15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., 
publication bias, selective reporting within studies). 
Study 
Quality: 
paragraph 1 
Additional analyses 16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-
regression), if done, indicating which were pre-specified. 
Not 
applicable 
Risk of bias within 
studies 
19 Present data on risk of bias of each study and, if available, any outcome level assessment (see 
item 12). 
S4 
Results of individual 
studies 
20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary 
data for each intervention group (b) effect estimates and confidence intervals, ideally with a 
forest plot. 
S3, S4 
Synthesis of results 21 Present results of each meta-analysis done, including confidence intervals and measures of 
consistency. 
Results: 
throughout 
Risk of bias across 
studies 
22 Present results of any assessment of risk of bias across studies (see Item 15). Discussion: 
paragraphs 
8, 13, 14, 
and Study 
Limitations: 
throughout 
and S4 
 (S4-S9)Additional 
analysis 
23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-
regression [see Item 16]). 
Not 
applicable 
 DISCUSSION 
Summary of evidence 24 Summarize the main findings including the strength of evidence for each main outcome; 
consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). 
Discussion: 
paragraphs 
1-14 
Limitations 25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., 
incomplete retrieval of identified research, reporting bias). 
Discussion: 
paragraphs 
8, 13, 14, 
and Study 
Limitations: 
throughout 
Conclusions 26 Provide a general interpretation of the results in the context of other evidence, and implications 
for future research. 
Conclusion 
FUNDING 
Funding 27 Describe sources of funding for the systematic review and other support (e.g., supply of data); 
role of funders for the systematic review. 
Title Page 
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Review protocol 
Methods of the review: The study was conducted according to the PRISMA statement. 
Primary database: Five electronic databases (CINAHL, Cochrane Library, EMBASE, 
PubMed and Scopus).  
Search terms: 
Database Search Terms 
CINAHL ( (TI (Prevalence OR Incidence OR Epidemiology OR Mortality OR 
Recurr* OR Hospitali* OR Heali*OR heale* OR Amputat*) ) OR AB ( 
(Prevalence OR Incidence OR Epidemiology OR Mortality OR Recurr* 
OR Hospitali* OR heali* OR heale* OR Amputat*) ) ) AND ( (AB 
(Australia OR “Capital Territory” OR “Australian Capital Territory” OR 
Canberra OR “Northern Territory” OR Darwin OR “New South Wales” 
OR NSW OR Sydney OR Queensland OR Brisbane OR QLD OR 
“South Australia” OR Adelaide OR Tasmania OR Hobart OR Victoria 
OR Melbourne OR “Western Australia” OR Perth) ) OR TI ( (Australia 
OR “Capital Territory” OR “Australian Capital Territory” OR Canberra 
OR “Northern Territory” OR Darwin OR “New South Wales” OR NSW 
OR Sydney OR Queensland OR Brisbane OR QLD OR “South 
Australia” OR Adelaide OR Tasmania OR Hobart OR Victoria OR 
Melbourne OR “Western Australia” OR Perth) ) ) AND (AB ( (Diabet* 
OR foot OR pressure OR decubitus OR venous OR varicose OR stasis 
OR “insufficient artery” OR arteri* OR artery OR chronic) ) OR TI ( 
(Diabet* OR foot OR pressure OR decubitus OR venous OR varicose 
OR stasis OR “insufficient artery” OR arteri* OR artery OR chronic) ) ) 
AND (AB ( (Ulcer* OR wound* OR injur*) ) OR TI ( (Ulcer* OR wound* 
OR injur*) ) ) 
Cochrane (prevalence:ti,ab or incidence:ti,ab or epidemiology:ti,ab or 
mortality:ti,ab or recurr*:ti,ab or hospitali*:ti,ab or heali*:ti,ab or 
heale*:ti,ab or amputat*:ti,ab) and (Diabet*:ti,ab OR foot:ti,ab OR 
pressure:ti,ab OR decubitus:ti,ab OR venous:ti,ab OR varicose:ti,ab 
OR stasis:ti,ab OR “insufficient artery”:ti,ab OR arteri*:ti,ab OR 
chronic:ti,ab) and (Ulcer*:ti,ab OR wound*:ti,ab OR injur*:ti,ab) and 
(Australia:ti,ab or "Capital Territory":ti,ab or "Australian Capital 
Territory":ti,ab or Canberra:ti,ab OR "Northern Territory":ti,ab OR 
Darwin:ti,ab OR "New South Wales":ti,ab OR NSW:ti,ab OR 
Sydney:ti,ab OR Queensland:ti,ab OR Brisbane:ti,ab OR QLD:ti,ab OR 
"South Australia":ti,ab OR Adelaide:ti,ab OR Tasmania:ti,ab OR 
Hobart:ti,ab OR Victoria:ti,ab OR Melbourne:ti,ab OR "Western 
Australia":ti,ab OR Perth:ti,ab) 
EMBASE prevalence:ab,ti OR incidence:ab,ti OR epidemiology:ab,ti OR 
mortality:ab,ti OR recurrence:ab,ti OR hospitali:ab,ti OR heali*:ab,ti OR 
heale*:ab,ti OR amputat*:ab,ti AND (Diabet*:ab,ti OR foot:ab,ti OR 
pressure:ab,ti OR decubitus:ab,ti OR venous:ab,ti OR varicose:ab,ti 
OR stasis:ab,ti OR arteria*:ab,ti OR arterie*:ab,ti OR chronic:ab,ti) AND 
(ulcer*:ab,ti OR wound*:ab,ti OR injur*:ab,ti) AND (australia:ab,ti OR 
'capital territory':ab,ti OR 'australian capital territory':ab,ti OR 
canberra:ab,ti OR “Northern Territory”:ab,ti OR Darwin:ab,ti OR “New 
South Wales”:ab,ti OR NSW:ab,ti OR Sydney:ab,ti OR 
Queensland:ab,ti OR Brisbane:ab,ti OR QLD:ab,ti OR “South 
Australia”:ab,ti OR Adelaide:ab,ti OR Tasmania:ab,ti OR Hobart:ab,ti 
OR Victoria:ab,ti OR Melbourne:ab,ti OR “Western Australia”:ab,ti OR 
Perth:ab,ti) 
PubMed (Prevalence[Title/Abstract] OR Incidence[Title/Abstract] OR 
Epidemiology[Title/Abstract] OR Mortality[Title/Abstract] OR 
Recurr*[Title/Abstract] OR Hospitali*[Title/Abstract] OR 
Heale*[Title/Abstract] OR Heali*[Title/Abstract] OR 
Amputat*[Title/Abstract]) AND (Diabet*[Title/Abstract] OR 
foot[Title/Abstract] OR pressure[Title/Abstract] OR 
decubitus[Title/Abstract] OR venous[Title/Abstract] OR 
varicose[Title/Abstract] OR stasis[Title/Abstract] OR 
arteria*[Title/Abstract] OR arterie*[Title/Abstract] OR 
artery[Title/Abstract] OR chronic[Title/Abstract]) AND 
(Ulcer*[Title/Abstract] OR wound*[Title/Abstract] OR 
injur*[Title/Abstract]) AND (Australia[Title/Abstract] OR “Capital 
Territory”[Title/Abstract] OR “Australian Capital Territory”[Title/Abstract] 
OR Canberra[Title/Abstract] OR “Northern Territory” [Title/Abstract] OR 
Darwin[Title/Abstract] OR “New South Wales”[Title/Abstract] OR 
NSW[Title/Abstract] OR Sydney[Title/Abstract] OR 
Queensland[Title/Abstract] OR Brisbane[Title/Abstract] OR 
QLD[Title/Abstract] OR “South Australia” [Title/Abstract] OR 
Adelaide[Title/Abstract] OR Tasmania[Title/Abstract] OR 
Hobart[Title/Abstract] OR Victoria[Title/Abstract] OR 
Melbourne[Title/Abstract] OR “Western Australia”[Title/Abstract] OR 
Perth[Title/Abstract]) 
Scopus ( TITLE-ABS-KEY ( Prevalence OR Incidence OR Epidemiology OR 
Mortality OR Recurr* OR Hospitali* OR Heali* OR Heale* OR Amputat* 
) ) AND ( TITLE-ABS-KEY (Diabet* OR foot OR pressure OR decubitus 
OR venous OR varicose OR stasis OR arterie* OR arteria* OR arteri * 
OR chronic) ) AND ( TITLE-ABS-KEY ( Ulcer* OR wound* OR injur* ) ) 
AND (TITLE-ABS-KEY ( Australia OR “Capital Territory” OR “Australian 
Capital Territory” OR Canberra OR “Northern Territory” OR Darwin OR 
“New South Wales” OR NSW OR Sydney OR Queensland OR 
Brisbane OR QLD OR “South Australia” OR Adelaide OR Tasmania 
OR Hobart OR Victoria OR Melbourne OR “Western Australia” OR 
Perth ) ) 
Inclusion and Exclusion Criteria 
Inclusion Exclusion 
Published studies or reports Unpublished studies or reports 
Primary data sources Secondary data sources (abstracts, letters, 
editorials, reviews, protocols, etc.) 
Related to outcomes of interest: 
prevalence, incidence, infection, 
hospitalisation, amputation, healing or 
recurrence (search terms: Group 1) 
Related to other outcomes 
Related to chronic wounds: arterial ulcers, 
diabetic foot ulcers, pressure injuries or 
venous leg ulcers (search terms: Group 2, 
Group 3) 
Related to other types of wounds (e.g. 
surgical wounds, acute wounds) 
Undertaken in Australia (at any level: 
national, state / territory or regional / local) 
Studies undertaken in other countries; 
studies where Australia was included but 
(search terms: Group 4) results were combined with other countries 
Additional Information on Eligibility Criteria 
Articles initially excluded if: (1) they were duplicates, or (2) if the title clearly 
demonstrates that the focus of the article is not on clinical and epidemiological 
parameters or chronic wounds in an Australian setting. Articles are then excluded 
based on the following: 
 The study is a secondary data source
 The study relates to surgical wounds or acute wounds only
 The study is conducted internationally where Australia was included but
results were combined with other countries and separate estimates were not 
available for Australia 
 The study contained ambiguous data (e.g. it is not possible to separate DFUs
from diabetic foot complications more generally) 
Study inclusion/exclusion is completed independently (SR and LM). Results are 
reviewed and any disagreement is recorded. Results are discussed with RP to reach 
consensus. 
Data Abstraction Form 
Identification of Study 
1. Record the first authors’ surname
2. Record the year of publication
Characteristics of Study 
3. Record the state of publication
4. Record the setting
5. Record the study type and length
6. Record the sample type
7. Record the sample size
8. Record the quality score
Other Data 
9. Record estimates for epidemiological and / or clinical parameters
Quality Assessment 
The quality of the selected sources was assessed using a tool designed to assess risk of 
bias in population-based prevalence studies (20), and modified for our study. In Question 2, 
the definition of ‘representativeness’ was adjusted; consistent with the focus of this review, 
this was evaluated according to whether the study population was: (a) representative of an 
Australian state or territory population, (b) representative of an urban and rural population, or 
(c) not representative. In Question 7, which asks about the measurement of the outcomes(s) 
of interest, the use of either a reliable and valid tool or other standard clinical diagnostic 
criteria was considered suitable. Question 9 on the original tool, which asks about length a 
prevalence period, was deleted due to lack of relevance to this review’s broader focus.  
EXTERNAL VALIDITY 
1) Was the study’s target population a close representation of the state/territory
population in relation to relevant variables, e.g. age, sex? 
 Representative for Australian state/territory-level = 2 (e.g. multisite, rural AND urban)
 Captured estimates for a rural and urban sample = 1 (e.g. multisite, rural OR urban)
 Captures estimates for only a rural or urban sample = 0 (e.g. single site, rural OR urban)
2) Was the sampling frame a true or close representation of the target population?
 Yes = 1
 No = 0
3) Was some form of random selection used to select the sample, OR was a
census undertaken? 
 Yes = 1
 No = 0
4) Was the likelihood of non-response bias minimal?
 80% or higher = 1 (e.g. ≥80% response / participation rate; ≤20% loss to follow-up, etc.)
 79% or lower = 0 (e.g. ≤80% response / participation rate; ≥20% loss to follow-up, etc.)
INTERNAL VALIDITY 
5) Were data collected directly from the subjects (as opposed to a proxy)?
 Directly = 1
 Proxy = 0
6) Was an acceptable case definition used in the study?
 Yes = 1 (e.g. wound type(s) were defined, or classified using a standardised tool)
 No = 0 (e.g. wound type(s) were not defined or classified)
7) Was the outcome of interest measured or assessed using a reliable and valid
tool and / or standard diagnostic criteria? 
 Yes = 1
 No = 0
8) Was the same mode of data collection used for all subjects?
 Yes = 1
 No = 0
9) Were the numerator(s) and denominator(s) for the parameter(s) of interest
appropriate? 
 Yes = 1
 No = 0
The total quality score for each study is the sum of the scores for individual assessment 
items. This is converted to a proportional quality score (the total quality score divided by the 
maximum score possible) and expressed as a percentage. 
Data extraction and quality assessment is completed independently (SR and LM). Results 
are reviewed and where disagreement occurs results are discussed with RP to reach 
consensus. 
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Summary of Study Characteristics 
First author 
(reference) 
Year State Setting Study type and 
length 
Sample Sample 
size 
Quality 
score 
Parameters and findings 
Studies of arterial ulcers (AU) 
Baker (28) 1992 WA Fremantle 
Hospital, Perth 
Prospective cross-
sectional 
Study period = 3 
months 
All people: (1) referred and 
presenting to a specialist wound 
clinic with leg ulcer(s) of ≥1 
month duration in the study 
period, and (2) who were fully 
assessed (93% of sample) 
242 70% Arterial disease was found in: 
- 45/239 limbs with ulcers (18.8%) – mixed cause 
- 21/239 limbs with ulcers (8.8%) – primary cause 
- 35/47 feet with ulcers (74.5%) – mixed / primary cause 
- 60/208 fully-investigated people (28.8%) 
Carville (29) 1998 WA Silver Chain 
home care 
service area 
Prospective cross-
sectional 
Study period = 7 
days 
All people attending a community 
nursing service, with a current 
wound and wound care plan, in 
the study week 
Not 
specified 
60% - 817 people had LUs (48.2% of all wounds) 
- Of these, 78/817 (9.5%) had an AU 
Carville (30) 2004 WA Silver Chain 
home care 
service area 
Prospective cohort 
Study period = 
approx. 5 months 
All people presenting to the 
service with any type of wound 
(chronic or otherwise); clients 
were veterans.  
155 60% - 47.0% of people presented with a LU 
- 18.0% (n = 19) of these LUs were AUs 
Edwards (9) 2013 QLD Community 
specialist wound 
clinic and 
hospital 
outpatient 
wound clinic 
Retrospective 
cross-sectional 
survey 
Study period = 1 
year 
Prospective 
longitudinal 
Study period = 6 
months 
All people attending one of the 
participating clinics with a non-
malignant ulcer below the knee 
Retrospec.
= 104 
Prospec. = 
70 
60% Of the people with LUs included in the study:  
- 6/70 people had an AU (8.6%)  
- 1/6 people had signs of AU infection (16.7%) 
[This paper also reported median time to healing, but in 
a graph which could not be accurately read.] 
Hoskins (31) 1997 NSW Various public 
and private 
community 
healthcare 
providers 
Prospective cohort 
Study period = 3 
months 
All people presenting to one of 
the participating community 
healthcare providers with a leg 
ulcer 
330 60% Of the people with LUs included in this study: 
- 10.0% had an AU (n = 33) 
Jopp-McKay (32) 1991 WA Leg ulcer clinic, 
Fremantle 
Hospital, Perth 
Prospective cohort 
Study period = 1 
year 
All people referred to the clinic in 
the study period 
116 50% Of the people with LUs included in the study: 
- 4/135 ulcerated limbs (3.0%) had an AU – primary 
  cause 
- 23/135 ulcerated limbs (17.0 %) had an AU – mixed 
  cause 
Liew (33) 1998 TAS Leg ulcer clinic, 
Repatriation 
Hospital, Hobart 
Prospective cohort 
Study period = 40 
months 
All people attending the leg ulcer 
clinic 
345 50% Of the people with LUs included in the study, 19.0% (n = 
61) had an AU
Muller (34) 1999 QLD Royal Brisbane 
Hospital ulcer 
clinic 
Prospective cohort 
Study period = 1 
year 
All people presenting to the 
service 
112 40% Of the people with LUs included in the study: 
- 4.5% (n = 5) had an AU – primary cause 
- 9.8% (n = 11) had an AU – mixed cause 
Rayner (36) 2007 WA Nurse-led rural 
community 
wound clinic, 
Bunbury 
Prospective cross-
sectional 
Study period = 1 
year 
All people presenting to the clinic 
with a wound (chronic or 
otherwise) 
53 40% Of the 53 people with 64 wounds in in the study: 
- 10.9% (n = 7) of wounds were an AU 
- 33.3% (n = 6) of AUs healed in ≤12 months 
 Santamaria (35) 2004 WA Clinics in the 
Kimberley region 
Prospective 
randomised 
controlled trial 
Study period = 1 
year 
All people: (1) presenting to the 
service, and (2) with a chronic 
lower extremity ulcer 
Total = 93 
Study = 50 
Control = 
43 
80% Of the people included in the study: 
- 3/93 (3.2%) had an AU – primary cause 
- 1.0% in the intervention group had an AU 
- 2.0% in the control group had an AU 
Walker (37) 2014 VIC Gippsland 
region 
Retrospective 
cross-sectional 
Study period = 2 
years 
All people with any wound 
(chronic or otherwise) 
documented in the Mobile 
Wound Care database 
1762 60% Of the people included in the study:  
- 24/2356 (1.0%) wounds were AU – primary cause 
- Median time to healing = 107.0 days 
First author 
(reference) 
Year State Setting Study type and 
length 
Sample Sample 
size 
Quality 
score 
Parameters and findings 
Studies of diabetic foot ulcers (DFU) 
Baba (38) 2014 WA Fremantle 
region 
Prospective cohort 
Study period = 3 
years 3 month 
All people with diabetes mellitus 
presenting to pre-defined health 
care services 
2258 80% Of the people with diabetes mellitus in this study: 
- 1.2% had a DFU 
- In people with DFUs, incidence of first-time 
  hospitalisation was 6.2%; 54.4% of these people were 
  admitted with the DFU as the primary problem 
- The incidence of first-ever hospital admission for DFU 
  was 5.21 per 1000 patient-years; 6.01 per 1000  
  patient-years in men and 4.53 per 1000 patient-years 
  in women 
Baba (39) 2015 WA Fremantle 
region 
Prospective cohort 
Study period = 3 
years 3 month 
All people with diabetes mellitus 
presenting to pre-defined health 
care services 
2258 80% Of the people with diabetes mellitus in this study:  
- 1.2% to 1.5% had a DFU 
- 0.5% to 1.8% had been hospitalised for DFU prior to 
  the beginning of the study 
 Baker (28) 1992 WA Fremantle 
Hospital, Perth 
Prospective cross-
sectional 
Study period = 3 
months 
All people: (1) referred and 
presenting to a specialist wound 
clinic with leg ulcer(s) of ≥1 
month duration in the study 
period, and (2) who were fully 
assessed (93% of sample) 
242 70% Diabetes mellitus was found in: 
- 29/239 limbs with ulcers (12.1%) – mixed cause 
- 6/239 limb with ulcers (2.5%) – primary cause 
- 23/47 feet with ulcers (48.9%) – mixed or primary 
  cause 
- 28/208 fully-investigated people (13.5%) 
Clarke (40) 2008 WA Hospital and 
primary 
healthcare 
services state-
wide 
Retrospective 
longitudinal 
Study period = 10 
years 
All people with diabetes mellitus 70 340 70% A DFU was recorded in:  
- 703/70 340 (1.0%) of people in their first year of 
  diabetes mellitus 
- 1730/70 340 (2.5%) of people throughout their 
  history of diabetes mellitus 
Commons (95) 2015 NT Royal Darwin 
Hospital, Darwin 
Prospective cross-
sectional 
Study period = 15 
months 
All people admitted as inpatients 
with a diabetic foot infection 
177 60% - Hospital admission for an infected DFU occurred in 
  177 people = incidence of 79 admissions per 100 000 
  person years  
Of the people admitted with an infected DFU:  
- 54 (30.5%) of people had ≥1 minor amputation 
- 14/54 (26.0%) with 1 minor amputation required a 
  second minor amputation 
- 10/54 (18.5%) with 1 minor amputation required a 
  second major amputation 
- 17 (9.6%) of people had ≥1 major amputation 
- The median duration of hospital stay = 29.0 days 
Davis (97) 2006 WA Fremantle 
region 
Prospective cohort 
Study period = 3 
years 3 month 
All people with diabetes mellitus 
presenting to pre-defined health 
care services 
2258 80% - DFU was a significant independent predictor of first-
ever lower-extremity amputation in people with diabetes 
mellitus (hazard ratio [95% CI]: 5.56 [1.24-25.01]) 
Edwards (9) 2013 QLD Community 
specialist wound 
clinic and 
hospital 
outpatient 
wound clinic 
Retrospective 
cross-sectional 
survey 
Study period = 1 
year 
Prospective 
longitudinal 
Study period = 6 
months 
All people with a non-malignant 
ulcer below the knee 
Retrospec.
= 104 
Prospec. = 
70 
60% Of the people with LUs included in the study:  
- 6/70 (8.6%) people had a DFU 
- 1/6 (16.7%) people had signs of DFU infection 
[This paper also reported median time to healing, but in 
a graph which could not be accurately read.] 
Ewald (98) 2001 NT Regional 
hospitals in Alice 
Springs and 
Tennant Creek 
Retrospective 
cohort 
Study period = 7 
years 
All people with diabetes mellitus 
presenting to the two 
participating hospitals, who 
underwent a ‘separation’ 
(amputation) in the study period  
3520 60% Of the people with diabetes mellitus in this study:  
- 7.0% had an amputation (minor or major), of which 
  34.0% were a direct result of DFUs 
Haji Zaine (92) 2014 NSW Western Sydney Retrospective 
cohort 
Study period = 1 
year 
All people with diabetes mellitus 
and a DFU 
195 70% Of 195 people with DFUs: 
- 7/195 (3.6%) people had recurrent DFU(s) 
- 97/195 (49.7%) had signs of DFU infection 
- 1/195 (0.5%) had a major amputation 
- 4/195 (2.1%) had a minor amputation  
Jopp-McKay (32) 1991 WA Leg ulcer clinic, 
Fremantle 
Hospital, Perth 
Prospective cohort 
Study period = 1 
year 
All people referred to the clinic in 
the study period 
116 50% Of the people with LUs included in the study: 
- 5/135 ulcerated limbs (3.7%) had a DFU – primary 
  cause 
- 22/135 ulcerated limbs (16.3%) had a DFU – mixed 
  cause 
Lazzarini (42) 2013 QLD State-wide Prospective cohort 
Study period = 1 
year 
All people: (1) with a foot ulcer, 
and (2) registered with a 
Queensland High Risk Foot 
2034 70% - 2034 people presented with a foot ulcer; of these, 
  85.0% had a diagnosis of diabetes mellitus 
- Median time to ulcer healing was 6.0 weeks 
- 37.0% of people experience ulcer recurrence 
Lim (99) 2006 WA Department of 
Vascular 
Surgery, Royal 
Perth Hospital, 
Perth 
Retrospective 
cross-sectional 
Study period = 2 
years 
All people who underwent major 
lower limb amputation 
87 50% The most common cause of major lower-limb 
amputation were:  
- Diabetic foot infection (15/87 = 17.2%); diabetes 
  was present in 43/87 (49.4%) of people receiving 
  a major lower-limb amputation 
McGill (88) 2005 NSW Diabetes Centre, 
Royal Prince 
Albert Hospital, 
Sydney 
Prospective case-
control 
Study period = 2.5 
years 
All people: (1) aged <65 years at 
baseline, with (2) diabetes 
mellitus, (3) neuropathy or no 
neuropathy, and (4) no active 
foot lesion 
2700 60% Of the people included in the study:  
- 6 people with diabetic neuropathy developed a DFU 
  (34 ulcers); annual incidence 6.3%  
- 3 people without diabetic neuropathy developed a DFU 
  (3 ulcers);  annual incidence 0.5% 
Muller (34) 1999 QLD Royal Brisbane 
Hospital ulcer 
clinic 
Prospective cohort 
Study period = 1 
year 
All people presenting to the 
service 
112 40% Of the people included in the study: 
- 9.0% (n = 10) had a DFU 
- 5.4% (n = 6) of these ulcers were neuropathic 
- 3.6% (n = 4) of these ulcers were neuro-ischaemic 
O’Rourke (96) 2002 NT High Risk Foot 
Service, Royal 
Darwin Hospital, 
Darwin 
Prospective cross-
sectional 
Study period = 3 
years 
All people presenting to the 
service, as inpatients or 
outpatients 
126 80% Of the people with DFUs included in the study: 
- 46/126 (36.5%) had a minor amputation 
- 29/126 (23.0%) had a major amputation  
Perrin (41) 2006 VIC Diabetic Foot 
Clinic, Bendigo 
Hospital, 
Bendigo 
Retrospective 
cross-sectional 
Study period = 2 
years 
All people: (1) presenting to the 
clinic, and (2) whose medical 
histories were examined (79% of 
total people presenting) 
181 50% Of the people included in the study:  
- 59/181 (32.6%) had a DFU; 123 wounds in total 
- 18/123 (14.6%) of DFUs showed signs of infection 
- There were 13 amputations 
- The mean time to healing was 15.7 weeks 
- 47.0% of DFUs healed in 12 weeks 
- 72.0% of DFUs healed in 20 weeks 
Perrin (87) 2011 VIC Not specified Prospective cohort 
Study period = not 
specified 
All people recruited into the 
study 
121 30% In the study period 34.2% of people developed a new 
DFU.  
Perrin (86) 2012 VIC Community and 
hospital podiatry 
service, Bendigo 
Prospective cross-
sectional 
Study period = 3 
months 
All people: (1) presenting to the 
service, and (2) with diabetes 
mellitus 
576 80% - Of the people included in this study 36/576 
  (6.3%) developed a new DFU during the study 
  period 
Rodrigues (22) 2016 QLD High Risk Foot 
Clinic, 
Townsville 
Hospital, 
Townsville 
Retrospective 
case-control 
Study period = 3 
years 
All people: (1) presenting to the 
service, with (2) diabetes 
mellitus, and (3) a DFU 
129 40% Of the people with DFUs included in the study: 
- 44/129 (34.1%) received an amputation  
- 35/129 (27.1%) required a minor amputation  
- 9/129 (7.0%) required a major amputation  
Santamaria (35) 2004 WA Clinics in the 
Kimberley region 
Prospective 
randomised 
controlled trial 
Study period = 1 
year 
All people: (1) presenting to the 
service, and (2) with a chronic 
lower extremity ulcer 
Total = 93 
Study = 50 
Control = 
43 
80% Of the people included in the study: 
- 36/93 (38.7%) had a DFU 
- 27.0% in the intervention group had a DFU 
- 12.0% in the control group had a DFU 
Santamaria (100) 2012 VIC Diabetic Foot 
Unit, Royal 
Melbourne 
Hospital, 
Melbourne 
Prospective cohort 
Study period = 2 
years 
All people treated for DFUs 95 50% Of the people with DFUs included in the study (228 
wounds in total):  
- 74.8% had all wounds healed ≤ 28 days 
- 8.4% had all wounds healed ≥ 28 days 
Tapp (89) 2003 Australia Nationwide Retrospective 
cross-sectional 
Study period = 2 
years 
A random sample of adults from 
the Obesity and Lifestyle Study, 
with and without diabetes 
mellitus 
2476 70% - Of the people included in the study, 19.6% were 
  considered to be ‘at risk’ of developing a DFU 
Walker (37) 2014 VIC Gippsland 
region 
Retrospective 
cross-sectional 
Study period = 2 
years 
All people with chronic wounds 
documented in the Mobile 
Wound Care database 
1762 60% Of the people included in the study:  
- 61/2356 (2.6%) wounds were DFU / neuropathic 
- Median time to healing = 66.3 days 
First author 
(reference) 
Year State Setting Study type and 
length 
Sample Sample 
size 
Quality 
score 
Parameters and findings 
Studies of venous leg ulcers (VLU) 
Baker (21) 1991 WA Vascular 
Laboratory, 
Fremantle 
Hospital, Perth 
Prospective cross-
sectional 
Study period = 3 
months 
All people: (1) referred and 
presenting to a specialist wound 
clinic with leg ulcer(s) of ≥1 
month duration in the study 
period, and (2) who were fully 
assessed (93% of sample) 
242 70% Of the people with LUs included in the study: 
- 57.0% had venous disease; prevalence = 0.62/1000 
- In people ≥60 years, prevalence = 3.3/1000 
- 76.0% of people with a VLU had a previous VLU 
Baker (28) 1992 WA Fremantle 
Hospital, Perth 
Prospective cross-
sectional 
Study period = 3 
months 
All people: (1) referred and 
presenting to a specialist wound 
clinic with leg ulcer(s) of ≥1 
month duration in the study 
period, and (2) who were fully 
assessed (93% of sample) 
242 70% Venous disease was found in: 
- 58/239 limbs with ulcers (24.3%) – mixed cause 
- 102/239 limbs with ulcers (42.7%) – primary cause 
- 3/47 feet with ulcers (6.4%) – mixed or primary cause 
- 136/208 fully-investigated people (65.4%) 
Carville (29) 1998 WA Silver Chain 
home care 
service area 
Prospective cross-
sectional 
Study period = 7 
days 
All people attending a community 
nursing service, with  a current 
wound and wound care plan, in 
the study week 
Not 
specified 
70% - 817 people had LUs (48.2% of all wounds) 
- Of these, 233/817 (28.5%) were VLUs 
Carville (30) 2004 WA Silver Chain 
home care 
service area 
Prospective cohort 
Study period = 
approx. 5 months 
All people presenting to the 
service with a wound; clients 
were veterans.  
155 60% - 47.0% of people presented with a LU 
- 36.0% (n = 38) of these LUs were VLUs 
Charles (43) 2014 NSW General 
practitioners 
(GPs) 
participating in 
BEACH study 
Prospective 
longitudinal 
Study period = 1 
year 
All people presenting to a GP 
participating in the BEACH 
study; defined LUs as per the 
International Classification of 
Primary Care (ICPC-2) 
Not 
specified 
50% Prevalence of skin ulcers (general) = 7 per 1000 patient 
encounters (0.07%), of which VLUs represented 8.0% 
Edwards (93) 2005 QLD St Luke’s 
Nursing Service, 
Brisbane / Gold 
Coast 
Prospective 
randomised 
controlled trial 
Study period = 3 
months 
All people with: (1) an existing 
VLU,  and (2) an Ankle Brachial 
Pressure Index (ABPI) of >0.8 
and <1.3 
Total = 33 
Study = 
16 
Control = 
17 
70% Of the people with VLUs included in the study: 
- 73.0% had a history of previous VLU  
- Healing at 12 weeks: 7/16 = 43.6% in 
  intervention group; 4/17 = 23.5% in control  
  group (difference not statistically significant) 
- Infection: 1/16 = 6.3% in the intervention 
  group; 1/17 = 5.9% in the control group  
Edwards (101) 2005 QLD St Luke’s 
Nursing Service, 
Brisbane / Gold 
Coast 
Prospective 
randomised 
controlled trial 
Study period = 3 
months 
All people with: (1) an existing 
VLU,  and (2) an Ankle Brachial 
Pressure Index (ABPI) of >0.8 
and <1.3 
Total = 56 
Study = 
28 
Control = 
28 
70% Of the people with VLUs included in the study: 
- Healing at 12 weeks: 46.2% in intervention group; 
  25.9% in control group 
  group (difference not statistically significant) 
Edwards (104) 2009 QLD Spiritus 
(formerly St 
Luke’s) Nursing 
Service, 
Brisbane / Gold 
Coast 
Prospective 
randomised 
controlled trial 
Study period = 6 
months 
All people with: (1) an existing 
VLU,  and (2) an Ankle Brachial 
Pressure Index (ABPI) of >0.8 
and <1.3 
Total = 67 
Study = 
34 
Control = 
33 
60% Of the people with VLUs included in the study: 
- Healing at 24 weeks: 15/26 = 57.6% in  
  intervention group; 10/26 = 38.5% in control 
  group (difference not statistically significant) 
Edwards (9) 2013 QLD Community 
specialist wound 
clinic and 
hospital 
outpatient 
wound clinic 
Retrospective 
cross-sectional 
survey 
Study period = 1 
year 
Prospective 
longitudinal 
Study period = 6 
months 
All people attending one of the 
participating clinics with a non-
malignant ulcer below the knee 
Retrospec.
= 104 
Prospec. = 
70 
60% Of the people with LUs included in the study:  
- 32/70 (45.7%) people had a VLU  
- 4/32 (12.5%) people had signs of VLU infection 
- 20/32 (62.5%) of VLUs healed in <12 weeks with 
  treatment in a specialist wound clinic 
- Recurrence at 3 mths after healing = 1/18 (5.6%) 
- Recurrence at 12 mths after healing = 3/18 (16.7%) 
- Median time to recurrence = 63 weeks 
[This paper also reported median time to healing, but in 
a graph which could not be accurately read.] 
Finlayson (109) 2009 QLD Community- and 
hospital-based 
leg ulcer clinics 
Cross-sectional 
survey plus chart 
review 
Study period = 2 
years 
All people attending one of the 
participating clinics with a VLU, 
completely healed for ≥2 weeks 
122 70% Of the people with VLUs included in this study:  
- 36.0% (n = 44) experienced recurrence ≤3 months 
- An additional 20.0% (n = 22) experienced recurrence in 
  12 months 
Finlayson (106) 2014 QLD Community- and 
hospital-based 
leg ulcer clinics 
Randomised 
controlled trial 
Study period = 3 
years 
All people attending one of the 
participating clinics: (1) with a 
VLU of ≥1cm2, and (2) with an 
Ankle Brachial Pressure Index 
(ABPI) of >0.8 and <1.3 
103 80% Of the people with VLUs included in this study: 
- 84.0% who received a four-layer compression 
  system healed in ≤24 weeks; mean percentage of 
  reduction in VLU size = 96.0% 
- 72.0% who received a three-layer compression 
  system healed in ≤24 weeks; mean percentage of 
  reduction in VLU size = 93.0% 
Hoskins (31) 1997 NSW Various public 
and private 
community 
healthcare 
providers 
Prospective cohort 
Study period = 3 
months 
All people presenting to one of 
the participating community 
healthcare providers with a leg 
ulcer 
330 60% Of the people with LUs included in this study: 
- 27.6% had a VLU (n = 91) 
Jopp-McKay (32) 1991 WA Leg ulcer clinic, 
Fremantle 
Hospital, Perth 
Prospective cohort 
Study period = 1 
year 
All people referred to the clinic in 
the study period 
116 50% Of the people with LUs included in the study:  
- 57/135 ulcerated limbs (42.2%) had a VLU – primary 
  cause 
- 26/135 ulcerated limbs (19.3%) had a VLU – mixed 
  cause 
- 42/57 (73.6%) of limbs with VLUs healed in 6 months 
- 3/50 patients (6.0%) with VLUs required hospitalisation 
Kapp (94) 2013 VIC Home nursing 
service, 16 
geographic 
areas in Victoria 
Prospective 
randomised 
controlled trial 
Study period = 26 
weeks  
All people: (1) within 1 week of 
complete healing of all VLUs, 
and (2) with an Ankle Brachial 
Pressure Index (ABPI) of >0.8 
and <1.2 
93 70% Of the people with VLUs included in the study:  
- 81.7% had a previous VLU 
- 11/93 (11.8%) had a recurrence of the study VLU; 
  average time to recurrence = 77.9 days 
- Smaller number (not specified) had a recurrence 
  of an older VLU 
- 58.1% had a VLU infection prior to the study 
Liew (33) 1998 TAS Leg ulcer clinic, 
Repatriation 
Hospital, Hobart 
Prospective cohort 
Study period = 40 
months 
All people attending the leg ulcer 
clinic 
345 50% Of the people with LUs included in the study, 59.0% (n = 
193) had a VLU 
Muller (34) 1999 QLD Royal Brisbane 
Hospital ulcer 
clinic 
Prospective cohort 
Study period = 1 
year 
All people presenting to the 
service 
112 40% Of the people included in the study: 
- 70.5% (n = 79) had a VLU – primary cause 
- 9.8% (n = 11) had a VLU – mixed cause 
O’Brien (102) 2013 QLD Royal Brisbane 
Hospital 
outpatients’ 
clinic 
Randomised 
controlled trail 
Study period = 3 
months 
All people presenting to the 
service with a VLU 
11 
Study = 
6 
Control = 
5 
60% Of the people with a VLU included in the study: 
- 50.0% in the intervention group healed in ≤12 weeks; 
  average reduction in ulcer size = 77.0% 
- 40.0% in the usual care group healed in ≤12 weeks; 
  average reduction in ulcer size = 45.0% 
Parker (105) 2014 QLD Community leg 
ulcer clinic, 
Brisbane 
Prospective cohort 
and retrospective 
chart review 
Study period = 24 
weeks 
All people presenting to the clinic 
with a wound 
119 50% Of the people participating in this study:  
- 96.8% (n = 61) classified as ‘low risk’ had a VLU which 
  healed in ≤24 weeks 
- 75.0% (n = 6) classified as ‘high risk’ had a VLU which 
  did not heal in ≤24 weeks 
Rayner (36) 2007 WA Nurse-led rural 
community 
wound clinic, 
Bunbury 
Prospective cross-
sectional 
Study period = 1 
year 
All people presenting to the clinic 
with a wound 
53 40% Of the 53 people with 64 wounds in in the study: 
- 53.1% (n = 34) of wounds were a VLU 
- 67.7% (n = 21) of VLUs healed in ≤12 months 
Santamaria (35) 2004 WA Clinics in the 
Kimberley region 
Prospective 
randomised 
controlled trial 
Study period = 1 
year 
All people: (1) presenting to the 
service, and (2) with a chronic 
lower extremity ulcer 
Total = 93 
Study = 
50 
Control = 
43 
80% Of the people included in the study: 
- 8/93 (8.6%) had a VLU – primary cause 
- 7.5% in the intervention group had a VLU 
- 1.0% in the control group had a VLU 
Smith (108) 2010 VIC Not applicable Prospective cohort 
Study period = 2 
months 
All people with a chronic VLU (≥6 
weeks duration), with the 
cognitive / literacy skills 
necessary to complete a wound 
logbook 
14 50% Of the people included in the study:  
- 50.0% (n = 7) – “half” – had a recurrent VLU 
- Wound area decreased by an average of 43.0% 
  in the study period 
Stacey (107) 1997 WA Freemantle 
Hospital leg 
ulcer clinic 
Randomised 
controlled trial 
Study period = 9 
months 
All people: (1) presenting to the 
service, and (2) with a chronic 
VLU 
113 60% Healing of VLUs:  
- Dressing 1: 86.0% (37/43) people healed in ≤9 
  months; mean rate of reduction in wound size = 
  0.83cm2 per week  
- Dressing 2: 65.9% (29/44) people healed in ≤9 
  months; mean rate of reduction in wound size = 
  0.53cm2 per week 
- Dressing 3: 58.7% (27/46) people healed in ≤9 
  months; mean rate of reduction in wound size = 
  0.02cm2 per week 
Walker (37) 2014 VIC Gippsland 
region 
Retrospective 
cross-sectional 
Study period = 2 
years 
All people with chronic wounds 
documented in the Mobile 
Wound Care database 
1762 60% Of the people included in the study:  
- 73/2356 (3.1%) wounds were VLU – primary cause 
- Median time to healing = 63.9 days 
Weller (103) 2012 QLD, VIC Four specialised 
metropolitan 
wound clinics 
Prospective 
randomised 
controlled trial 
Study period = 2 
years 
All people: (1) who were 
ambulant, (2) had a VLU present 
for ≥4 weeks with an area of 
≥1cm2 to ≤20cm2, (3) and with an 
Ankle Brachial Pressure Index 
(ABPI) of >0.8 and <1.2 
Total = 45 
Study = 
23 
Control = 
22 
70% Of the people with VLUs included in the study:  
- 27/45 (60.0%) healed in the 12 week study period 
- 17/23 (73.9%) of ulcers in the study group healed 
- 10/22 (45.1%) ulcers in the control group healed 
- 6/26 (23.1%) of ulcers recurred; all recurrences 
  occurred within 5 weeks of healing 
First author 
(reference) 
Year State Setting Study type and 
length 
Sample Sample size Quality 
score 
Parameters and findings 
Studies of pressure injuries (PI) 
Asimus (53) 2011 NSW Hunter New 
England region 
Point prevalence 
survey 
Study period = 
points in  2009, 
2009 and 2010 
All people admitted to 
healthcare facilities in the 
study region 
2008 = 
1407 
2009 = 
1279 
2010 = 1331 
50% - In 2008, prevalence of PIs = 29.4% (884 PIs) 
- In 2008, prevalence of hospital-acquired PIs = 23.4% 
Following a PI prevention program:  
- In 2009, prevalence of PIs = 23.8% (611 PIs) 
- In 2009, prevalence of hospital-acquired PIs = 17.2% 
- In 2010, prevalence of PIs = 13.0% (344 PIs) 
- In 2010, prevalence of hospital-acquired PIs = 8.0% 
- Total number of Stage III/IV PIs decreased from 14.9% 
  (2009) to 13.9% (2010) 
Bail (68) 2013 NSW Hospitals state-
wide 
Retrospective 
cohort 
Study period = 2 
years 
All people aged ≥50 years 
admitted to a hospital for any 
reason and subsequently 
discharged 
426 276 70% Incidence of PIs:  
- In people in hospital aged >50 – medical = 4.2% 
- In people in hospital aged >50 – surgical = 4.9% 
- In people without dementia – medical = 3.8% 
- In people without dementia – surgical = 4.1% 
- In people with dementia – medical = 5.9% 
- In people with dementia – surgical = 7.3% 
Banks (75) 2010 QLD Multiple acute 
and residential 
aged care 
facilities in 
Brisbane 
Prospective cohort 
Study period = 1 
timepoint (T1), 
then another 
timepoint (T2) 1 
year later 
All people admitted to a 
participating facility on the day 
of the study 
3047 80% In the people living in residential aged care facilities in 
the study who were determined to be malnourished:  
- Prevalence of PI = 31.5% at T1  
- Prevalence of PI = 18.3% at T2 
- PU prevention guidelines were implemented  
  between T1 and T2 
Banks (25) 2016 QLD Royal Brisbane 
& Women’s 
Hospital, 
Herston 
Prospective 
randomised 
controlled trial 
Study period = 8 
months 
All people with an existing 
Stage II to IV PI 
50 60% With an intensive nutrition intervention, 18/31 (58.1%) of 
people had PI healed within their hospital admission 
(average 14 days, range 1 to 70 days).  
Barker (54) 2013 VIC Northern 
Hospital, 
Melbourne 
Prospective 
randomised 
controlled trial 
Study period = 
points in 2003, 
2004, 2006, 2007 
and 2011 
All people admitted to the 
hospital, in general wards, 
critical care and emergency 
departments 
1045 
2003 = 151 
2004 = 201 
2006 = 201 
2007 = 219 
2011 = 273 
60% Prevalence of PIs on admission to hospital: 
- 2003 = 9/151 (6.0%) 
- 2004 = 8/201(4.0%) 
- 2006 = 7/201 (3.5%) 
- 2007 = 5/219 (2.3%) 
- 2011 = 11/273 (4.0%) 
Prevalence of hospital-acquired PIs: 
- 2003 = 19/151 (12.6%) 
- 2004 = 23/201(11.5%) 
- 2006 = 16/201 (8.0%) 
- 2007 = 10/219 (4.6%) 
- 2011 = 7/273 (2.6%) 
Overall prevalence of PIs (on admission + hospital-
acquired):  
- 2003 = 28/151 (18.5%) 
- 2004 = 31/201(15.4% 
- 2006 = 23/201 (11.4%) 
- 2007 = 15/219 (6.5%) 
- 2011 = 18/273 (6.6%) 
Carville (30) 2004 WA Silver Chain 
home care 
service area 
Prospective cohort 
Study period = 
approx. 5 months 
All people presenting to the 
service with a wound; clients 
were veterans.  
155 60% - 47.0% of people presented with a wound 
- 6.0% (n = 9) of these wounds were PIs 
Charles (43) 2014 NSW General 
practitioners 
(GPs) 
participating in 
BEACH study 
Prospective 
longitudinal 
Study period = 1 
year 
All people presenting to a GP 
participating in the BEACH 
study; defined LUs as per the 
International Classification of 
Primary Care (ICPC-2) 
Not 
specified 
50% Prevalence of skin ulcers (general) = 7 per 1000 patient 
encounters (0.07%), of which PIs represented 5.0% 
Charlier (55) 2001 NSW Rural hospital Prospective cross-
sectional and 
longitudinal 
Study period = 
daily assessment 
for a maximum of 
7 days 
All people admitted to the 
hospital 
Point prev.= 
59 
Incidence= 
62 
80% Of the people included in this study:  
- 7/59 (11.8%) had PI(s); 4/59 (6.8%) had ≥2 PIs 
In the study period of 7 days:  
- 5 PIs developed in 4/62 people = incidence of 
  6.5% across PI Stages I-IV 
- 1/62 people had a PI of ≥Stage II (Stage II) = 
  incidence of 2.0% across PI Stages II, III and IV 
Clinical Excellence 
Commission (26) 
2017 NSW 16 NSW 
Department of 
Health Facilities 
Prospective cross-
sectional 
Study period = 
point prevalence, 
2 points (2015, 
2016) 
All people admitted to the 
participating facilities on the 
day of study, who consented to 
a skin inspection  
10 255 70% Prevalence of PIs:  
- Overall = 9.1% (6.1% hospital-acquired in 2015; 
  5.3% hospital-acquired in 2016) 
- In residential aged care clients = 10.3% 
- In community and outpatient clients = 7.7% 
- 44% of all PIs were Stage I 
Coyer (76) 2014 QLD Metropolitan 
hospital, East 
Coast 
Prospective cross-
sectional repeated 
measures 
Study period = 1 
day per month for 
6 months 
All people admitted to the 
hospital on the days of study 
132 40% - Community-acquired PIs = 4/132 (3.0%) 
- Hospital-acquired PIs = 17/132 (12.9%) 
- Medical device-related PIs (included in the count of 
  hospital-acquired PIs) = 8/132 (6.1%) 
Coyer (24) 2016 QLD All Queensland 
Health hospitals 
Retrospective 
longitudinal 
Study period = 2 
years 
Data from Queensland bedside 
audits including all people 
admitted to hospital with PIs of 
Stages II, III and IV 
7291 70% - Prevalence of hospital-acquired PIs = 3.4% (n = 7291) 
- Prevalence of PIs in ICU patients = 11.5% 
- Prevalence of Stage II PIs in ICU patients = 53.1% 
- Prevalence of PIs in non-ICU patients = 3.0% 
- Prevalence of Stage II PIs in non-ICU patients = 63.5% 
Coyer (78) 2015 QLD Royal Brisbane 
and Women’s 
Hospital, 
Herston 
Prospective cohort 
Study period = 12 
months 
All people admitted to an 
intensive care unit for ≥24 
hours 
207 
Case = 105 
Control = 
102 
60% - In the intervention group, 18.1% (19/105) people 
  developed a PI; 4/105 had a Stage II to IV PI 
- In the control group, 30.4% (31/102) people 
  developed a PI; 17/102 had a Stage II to IV PI 
Cubit (79) 2013 ACT Calvary 
Hospital, Bruce 
Prospective case-
control 
Study period = 2 
months 
All people ≥65 years and 
matched hospital files  
109 
Case = 51 
Control = 58 
80% Of the people included in this study:  
- 1/51 (2.0%) developed a PI in the case group 
- 6/58 (10.3%) developed a PI in the control group 
- All PIs were Stage I or Stage II  
Davenport (56) 1999 VIC Knox Private 
Hospital 
Prospective cross-
sectional 
Study period = 
point prevalence 
All consenting people admitted 
to the participating hospital on 
the day of the study 
Survey 1 = 
88 
Survey 2 = 
104 
40% Survey 1:  
- Prevalence of PIs = 13.6% of people had a 
  Stage II or greater PI 
Survey 2 (following a quality improvement activity): 
- Prevalence of PIs = 3.0% of people had a Stage  
  II or greater PI 
Ellis (71) 2006 Unspecified 23 nursing 
homes 
Prospective cohort 
Study period = not 
specified 
All people in the participating 
nursing homes 
Not 
specified 
80% Prevalence of PIs:  
- Pre-intervention = 25.8% 
- Post-intervention = 16.6% 
Elliott (70) 2008 NSW Royal North 
Shore Hospital, 
Sydney 
Quasi-
experimental 
practice 
improvement 
Study period = 
2 years 
All people admitted to the 
participating hospital, in its 
intensive care unit, and 
consenting to a skin 
examination  
563 60% Prevalence of PIs:  
- 2003: 50.0% 
- 2005: 8.0% (after quality improvement project – for 
  example: the use of pressure-relieving devices) 
Gardner (63) 2009 VIC All three acute 
campuses of 
Cabrini Health 
Services 
Prospective cross-
sectional 
Study period = 
point prevalence 
All people, excluding 
newborns, admitted to the 
healthcare services on the day 
of the study 
252 60% Of the people included in this study:  
- Prevalence of PIs = 71/252 (28.2%) 
- Excluding Stage I PIs, prevalence = 9.9% 
- Stage I = 145/182 (79.7%); Stage II = 26/182 (14.3%); 
  Stage III = 1/182 (0.5%); Stage IV = 10/182 (5.5%) 
Graves (48) 2005 QLD Princess 
Alexandra 
Hospital, 
Woolloongabba 
Prospective cross-
sectional 
Study period = 3 
months 
A random sample of people 
admitted to the hospital 
1747 40% Of the people included in this study, 81/1747 (4.6%) had 
a PI.  
Hunter (57) 2014 QLD Bundaberg / 
Wide Bay region 
Retrospective 
cross-sectional 
Study period = 3 
years 
Data from the PRIME clinical 
incidents database 
Not known 50% Prevalence of PIs in study hospital / state (note: a PI 
prevention programme was implemented in the study 
hospital in 2011):  
- 2007 = 10.2% / - 
- 2008 – 13.6% / 12.0% 
- 2010 = 15.6% / 10.2% 
- 2011 (Jan) = 15.4% / - 
- 2011 (Oct) = 3.2% / 7.9% 
- 2012 = 4.3% / 7.0% 
- 2013 = 3.6% / 6.0% 
Jackson (49) 2011 VIC, QLD Hospitals state-
wide 
Retrospective 
cross-sectional 
Study period = 2 
years (VIC = 
2005/06, QLD = 
2006/07) 
All people admitted to a 
participating hospital, captured 
by a data-flag system for 
hospital-acquired conditions 
1 699 997 60% Prevalence of PIs = 2873 / 1 699 997 (0.2%) 
Jolley (83) 2004 VIC Royal 
Melbourne 
Hospital 
Randomised 
controlled trial 
Study period = 6 
months 
All people: (1) admitted to the 
participating hospital, (2) with 
an expected LOS of ≥2 days, 
and (3) assessed on admission 
to be at ‘low’ to ‘moderate risk’ 
of developing a PI 
441 
Study = 218 
Control = 
223 
50% Of the people included in this study:  
- 9.6% (n = 21) in the intervention group, who 
  were treated with Australian Medical Sheepskin, 
  developed a PI 
- 16.6% (n = 37) in the control group, who 
  received care as usual, developed a PI 
Lakhan (77) 2011 QLD Three acute 
hospitals, 
Brisbane 
Prospective cohort 
Study period = 3 
years 
All people aged ≥70 years 
admitted to a general medical 
ward for ≥24 hours 
577 50% Prevalence of PIs:  
- Premorbid = 9/576 (1.6%) 
- At admission = 28/577 (4.9%) 
- At discharge = 33/575 (5.7%) 
Lapsley (69) 1996 NSW One acute 
hospital in 
Sydney 
Prospective cohort 
Study period = 3 
years 
All people admitted to hospital 
for a coronary artery bypass or 
orthopaedic hip replacement 
3062 60% Of the people included in this study undergoing a 
coronary artery bypass graft:  
- 3.8% (n = 27, 1990), 1.6% (n = 12, 1991) and  
  2.9% (n = 24, 1992) developed a PI 
- Most PIs were Grade I (77.7%, 1990; 75.0%, 
  1991; 58.3%, 1992) 
- Mean LOS for people with a PI was 22.4 days 
  (versus 12.7 days for all patients) 
Of the people included in this study undergoing an 
orthopaedic hip replacement:  
- 10.2% (n = 27, 1990), 7.9% (n = 18, 1991) and  
  3.3% (n = 11, 1992) developed a PI 
- Most PIs were Grade I (63.0%, 1990; 66.7%, 
  1991; 72.7%, 1992) 
- Mean LOS for people with a PI was 31.2 days 
  (versus 19.7 days for all patients) 
Lewin (80) 2003 WA Silver Chain 
home care 
service area 
Prospective cross-
sectional 
Study period = 1 
month 
Adults at high risk of 
developing a PI  
175 70% Of the people included in this study:  
- Prevalence of PIs = 74 / 175 (42.3%) 
- Stage I = 112/167 (67.1%); Stage II = 45/167 (27%); 
  Stage III = 6/167 (3.6%); Stage IV = 4/167 (2.4%) 
Lewin (81) 2007 WA Silver Chain 
home care 
service area 
Prospective cross-
sectional 
Study period = 
point prevalence 
All people using the service, at 
high risk of developing a PI 
505 70% Prevalence of pressure ulcers: 
- 2002 = 74/175 (42.2%) 
- Stage I = 112/167 (67%); Stage II = 45/167 
  (26.9%); Stage III = 6/167 (3.6%); Stage IV = 
  4/167 (2.4%); Stage V 0/167 (0.0%) 
- 2003 = 56/147 (38.1%) 
- Stage I = 72/108 (66.7%); Stage II = 32/108 
  (29.6%); Stage III = 2/108 (1.9%); Stage IV = 
  0/108 (0.0%); Stage V 2/108 (1.9%) 
- 2004 = 35/183 (19.1%) 
- Stage I = 25/51 (49%); Stage II = 23/51 
  (45.1%); Stage III = 0/51 (0.0%); Stage IV = 
  3/51 (5.9%); Stage V 0/51 (0.0%) 
Liew (33) 1998 TAS Leg ulcer clinic, 
Repatriation 
Hospital, Hobart 
Prospective cohort 
Study period = 40 
months 
All people attending the leg 
ulcer clinic 
345 50% Of the people with LUs included in the study, 3.0% (n = 
9) had PI
Madsen (73) 1997 QLD Rockhampton Prospective cross-
sectional 
Study period = 
point prevalence 
All people admitted to the 
participating nursing homes on 
the day of the study 
Not specif-
ied 
80% - Prevalence rate of PIs = 0.03 (n = 4) 
- Stage I = 2, Stage II = 1, Stage 3 = 1 
Martin (58) 1994 VIC Heidelberg 
Repatriation 
Hospital 
Prospective cross-
sectional 
Study period = 
point prevalence 
All consenting people admitted 
to the participating hospital on 
the day of the study 
Not specif-
ied 
70% - Prevalence of PIs = 6.7% (24 people, 36 ulcers) 
- Of these PIs: Stage I = 28.0%; Stage II = 53.0%; 
  Stage III = 11.0%; Stage IV = 8.0% 
McErlean (59) 2002 SA Repatriation 
General Hospital 
Prospective cross-
sectional 
Study period = 
point prevalence 
All adults admitted to the 
hospital during the study 
period; average age = 72 years 
Not specif-
ied 
70% - Prevalence of PIs = 29.6% 
- Incidence of PI development = 20.6% 
Prevalence of PIs:  
- 2000: Stage I = 49.1%; Stage II = 46.0%; Stage 
  III = 5.1%; Stage IV = 0.0% 
- Prevention framework implemented in 2001 
- 2001 (Aug): Stage I = 59.2%; Stage II = 37.3%; 
  Stage III = 3.7%; Stage IV = 0.0% 
- 2001 (Dec): Stage I = 78.5%; Stage II = 21.4%; 
  Stage III = 3.6%; Stage IV = 0.0% 
McGowan (60) 1996 WA Freemantle 
Hospital, Perth 
Prospective cross-
sectional 
Study period = 
point prevalence 
All consenting people admitted 
to the participating hospital on 
the day of the study 
264 70% - Overall prevalence of PIs = 14.0% (37/264) 
- Overall prevalence of new hospital-acquired PIs 
  = 33/264 = 12 per 1000 
- 80.0% of all PIs were Stage I 
McGowan (90) 2000 WA Freemantle 
Hospital and 
Hollywood 
Hospital 
Randomised 
controlled trial 
Study period = 13 
weeks 
All people: (1) aged ≥60 years, 
(2) admitted with an 
orthopaedic diagnosis, and (3) 
assessed to be at ‘low’ or 
‘moderate’ risk of developing a 
PI  
297 
Study = 55 
Control = 
142 
70% Incidence of PIs:  
- In the intervention group (medical sheepskin): 
  9.0% (14/155) developed a PI 
- In the control group: 30.3% (43/142) developed a PI 
McRae (91) 2014 QLD Royal Brisbane 
& Women’s 
Hospital, 
Herston 
Prospective cohort 
Study period = 3 
months 
All people aged ≥65 years, 
admitted for a predicted stay of 
≥72 hours to a vascular 
surgical or urology ward 
112 40% Of the people included in this study, 5.0% developed a 
PI during hospitalisation.  
McRae (23) 2016 QLD Royal Brisbane 
& Women’s 
Hospital, 
Herston 
Prospective cohort 
Study period = 7 
months 
All people aged ≥65 years, 
admitted for a predicted stay of 
≥72 hours to a vascular 
surgical ward 
110 50% Of the people included in this study, 13/110 (11.8%) 
developed a PI.  
Miles (50) 2013 QLD Prince Charles 
Hospital, 
Brisbane 
Retrospective 
longitudinal 
Study period = 1 
day per year for 9 
years 
All people admitted to the 
hospital on the days of study 
Not known 60% Of the people included in this study, prevalence of 
hospital-acquired + community-acquired PI:  
- 2002: Incomplete data 
- 2003: Incomplete data  
- 2004: 34/246 (13.8%); 55 PIs total 
- 2005: 27/289 (9.3%); 38 PIs total 
- 2008: 55/356 (15.4%); 85 PIs total 
- 2009: 45/388 (11.6%); 69 PIs total 
- 2010: 21/349 (6%); 33 PIs total 
- 2011/i: 48/401 (12%); 63 PIs total 
- 2011/ii: 38/408 (9.3%); 51 PIs total 
- 2012:  21/327 (6.4%); 30 PIs total 
Morey (64) 1997 WA Sir Charles 
Gairdner 
Hospital, Perth 
Retrospective 
longitudinal 
Study period = 1 
day per year for 2 
years 
All people admitted to the 
hospital on the days of study 
1994 = 454 
1995 = 489 
70% Results in 1994:  
- 71/454 (15.6%) of people had a PI 
- 18/71 (14.8%) of PIs were community-acquired 
- Stage I = 51.6%; Stage II = 37.7%; Stage III =  
  5.7%; Stage IV = 4.9% 
- Incidence of hospital-acquired PIs = 12 per 100 
- Risk of developing a PI in hospital = 7.2 people  
  per 1000 bed days 
Results in 1995: 
- 71/489 (14.5%) of people had a PI 
- 38/71 (37.6%) of PIs were community-acquired 
- Stage I = 42.6%; Stage II = 49.5%; Stage III =  
  5.9%; Stage IV = 2.0% 
- Incidence of hospital-acquired PIs = 9.8 per 100 
- Risk of developing a PI in hospital = 7.6 people  
  per 1000 bed days 
Mulligan (61) 2011 WA Hospitals state-
wide 
Prospective cross-
sectional 
Study period = 
point prevalence 
All people admitted to the 
hospital on the days of study 
Not known 90% Of the people included in this study:  
- 2007: 10.9% had a PI; 42.4% (n = 213) were Stage I 
- 2008: 12.5% had a PI; 42.9% (n = 267) were Stage I 
- 2009: 9.5% had a PI; 38.4% (n = 163) were Stage I  
- 2011: 11.0% had a PI; 44.7% (n = 228) were Stage I 
Results from other similar studies reported in this paper:  
NSW:  
- 2008: 13.5% (from a cohort of 2813), 13.2% hospital-acquired 
- 2009: 11.0% (from a cohort of 1990); 9.4% hospital-acquired 
- 2011: 12.1% (from a cohort of 2013); 9.2% hospital-acquired 
QLD:  
- 2003: 18.0% (sample size not recorded); hospital-acquired not reported 
- 2009: 15.0% (from a cohort of 6371); 11.7% hospital-acquired 
SA: 
- 2007: 20.0% (from a cohort of 4298); 17.0% hospital-acquired 
VIC:  
- 2003: 26.5% (from a cohort of 6003); 18.0% hospital-acquired 
- 2004: 20.8% (from a cohort of 7621); 14.0% hospital-acquired 
- 2005: 17.6% (from a cohort of 7944); 12.0% hospital-acquired 
Pearson (51) 2000 NSW Hospitals in 
northern NSW 
Prospective cross-
sectional 
Study period = 
point prevalence 
All people admitted to the 
hospitals on the day of the 
study  
634 90% Of the people included in this study:  
- 40/634 (6.3%) had a PI; there were a total of 69 PIs 
- Most (54/67 ulcers, 80.6%) had a PI of Stage I / II 
Prentice (65) 2007 Multi-state 10 tertiary 
hospitals 
Prospective cohort 
Study period = 8 
months 
All people admitted to the 
hospitals on the day of the 
study 
Pre = 1706 
Post = 1807 
70% Of the people included in this study: 
- 26.5% (n = 452) had a PI at pre-intervention 
- 63.0% (n = 564) were Stage I  
- Mean LOS = 61.1 days 
- 22.0% (n = 396) had a PI at post-intervention 
- 59.0% (n = 390) were Stage I 
- Mean LOS = 58.5 days 
Quality and Safety 
Branch, Victorian 
Government 
Department of 
Human Services 
(66) 
2006 VIC All hospitals in 
Victoria 
Prospective cross-
sectional 
Study period = 
point prevalence 
All people admitted to the 
hospitals on the days of the 
study  
Not specif-
ied 
90% Prevalence of PIs: 
- 2003: 26.5% (67.6% hospital-acquired) 
- Stage I = 43.1% (n = 1153); Stage II = 44.2% (n 
  = 1183); Stage III = 4.5% (n = 120); Stage IV = 
  8.2% (n = 220) 
- 2004: 20.8% (66.2% hospital-acquired) 
- Stage I = 37.3% (n = 955); Stage II = 47.8% (n 
  = 1124); Stage III = 6.4% (n = 165); Stage IV = 
  8.4% (n = 215) 
- 2006: 17.6% (67.7% hospital-acquired) 
- Stage I = 40.4% (n = 848); Stage II = 47.0% (n 
   = 987); Stage III = 5.9% (n = 123); Stage IV = 
  6.8% (n = 142) 
Rayner (36) 2007 WA Nurse-led rural 
community 
wound clinic, 
Bunbury 
Prospective cross-
sectional 
Study period = 1 
year 
All people presenting to the 
clinic with a wound.  
53 40% Of the 53 people with 64 wounds in in the study: 
- 9.4% (n = 6) of wounds were a PI 
- All PIs healed in ≤12 months 
Roosen (52) 2010 QLD Prince Charles 
Hospital, 
Brisbane 
Prospective 
longitudinal 
Study period = 5 
years (intermittent) 
All people admitted, and 
captured in internal audit data 
Not known 40% Prevalence of PIs:  
- 2006 = 7.6% 
- 2008 = 13.7% (75 PIs identified, 57.0% at Stage I) 
- 2010 = 5.2%  
- Overall, 53.0% of the PIs were at Stage I 
Santamaria (35) 2004 WA Clinics in the 
Kimberley region 
Prospective 
randomised 
controlled trial 
Study period = 1 
year 
All people: (1) presenting to 
the service, and (2) with a 
chronic lower extremity ulcer 
Total = 93 
Study = 50 
Control = 43 
80% Of the people included in the study: 
- 14/93 (15.1%) had a PI 
- 3.0% in the intervention group had a PI 
- 12.0% in the control group had a PI 
Santamaria (72) 2005 VIC, WA, 
SA, NSW 
Nursing homes 
in various 
regions of the 
participating 
states 
Prospective cross-
sectional 
Study period = 3 
months 
All people living in the 
participating facilities 
1956 80% Of the people included in this study:  
- 122/471 (25.9%) had a PI 
- 205 (44.1%) had a Stage I PI; 204 (43.9%) had a Stage 
  II PI; 26 (5.6%) had a Stage III PI; 30 (6.5%) had a 
  Stage IV PI 
Santamaria (74) 2009 WA Hospitals and 
primary 
healthcare 
services state-
wide 
Prospective cohort 
Study period = 1 
month in 2007; 1 
month in 2008 
All consenting adult, paediatric, 
neonatal inpatients or aged-
care residents admitted in 
public hospitals on audit days 
2007 = 2777 
2008 = 3024 
70% - In 5801 people examined, prevalence of PIs = 9.0% 
- In 2007, prevalence of PIs = 303/2777 (10.9%) 
- 150 had a Stage I PI; 147 had a Stage II PI; 21 had a 
  Stage III PI; 22 had a Stage IV PI; 16 had an uncertain 
  staging 
- In 2008, prevalence of PIs = 377/3024 (12.5%) 
- 176 had a Stage I PI; 197 had a Stage II PI; 31 had a 
  Stage III PI; 22 had a Stage IV PI; 20 had an uncertain 
  staging 
Walker (37) 2014 VIC Gippsland 
region 
Retrospective 
cross-sectional 
Study period = 2 
years 
All people with chronic wounds 
documented in the Mobile 
Wound Care database 
1762 70% Of the people included in the study:  
- 258/2356 (11.0%) wounds were PI 
- 68 (26.4%) were Stage I; 124 (48.1%) were Stage II; 
  55 were Stage III (21.3%); 11 (4.3%) were Stage IV 
- Median time to healing = 57.9 days 
- For Stage I = 45.6 days; for Stage II = 56.5 days; for 
  Stage III = 58.9 days; for Stage IV = 58.3 days 
Webster (46) 2010 QLD Royal Brisbane 
& Women’s 
Hospital, 
Herston 
Prospective cohort 
Study period = 6 
weeks 
All people admitted to an 
internal medicine ward, with an 
expected stay of ≥72 hours 
274 70% Of the people included in this study:  
- 15/274 (5.5%) had an existing PI 
- 12/274 (4.4%) developed a new PI during admission 
Webster (44) 2011 QLD Royal Brisbane 
& Women’s 
Hospital, 
Herston 
Prospective cohort 
Study period = 9 
months 
All people admitted to an 
internal medicine or oncology 
ward, with an expected stay of 
≥72 hours 
820 60% Of the people included in this study:  
- 5.8% (n = 71) had an existing PI 
- Stage 1 = 36.6% (n = 21); Stage II = 39.4% (n = 
  28); Stage III = 8.5% (n = 6); Stage IV = 7.0% 
  (n = 5); unclassifiable = 8.5% (n = 6) 
Webster (45) 2015 QLD Royal Brisbane 
& Women’s 
Hospital, 
Herston 
Prospective cohort 
Study period = 3 
months 
All people booked for any 
surgical procedure expected to 
last >30 minutes 
534 60% Of the people included in this study: 
- 7/534 (1.3%) had a PI prior to surgery  
- 3 were Stage I; 2 were Stage II; 2 were un-stageable 
- 6/474 (1.3%) had a PI develop post-surgery 
- 4 were Stage I; 2 were Stage II 
Wright (47) 1996 VIC Royal 
Melbourne 
Hospital 
Prospective cross-
sectional 
Study period = 
point prevalence 
All consenting people admitted 
to the hospital on the day of 
the study 
554 80% Of the people included in the study: 
- 30/554 (5.4%) had a PI 
- 8/30 (26.7%) had a community-acquired PI 
- 16/30 (53.3%) had a hospital-acquired PI 
- 6/30 (20.0%) of people had a PI of undetermined origin 
- 29/45 (64.4%) of PIs were Stage I or Stage II 
- 14/45 (31.1%) of PIs were Stage III 
- 2/45 (4.4%) of PIs were Stage IV 
The authors report on a previous unpublished audit at 
the same hospital, undertaken in 1991, where the rate of 
PI was 6.6%.   
Young (62) 2000 TAS Launceston 
General Hospital 
Prospective cross-
sectional 
Study period = 
point prevalence 
All consenting people admitted 
to the hospital on the days of 
the study 
Not 
specified 
60% 1996:  
- Prevalence of PIs = 10.0% 
- Stage I = 50.0% (n = 9); Stage II = 11.0% (n = 
  2); Stage III = 23.0% (n = 4); Stage IV = 16.0% 
  (n = 3) 
1997:  
- Prevalence of PIs = 8.0% 
- Stage I = 6.0% (n = 1); Stage II = 13.0% (n = 
  2); Stage III = 81.0% (n = 13); Stage IV = 0% 
1998: 
- Prevalence of PIs = 9.0% 
- Stage I = 50.0% (n = 7); Stage II = 36.0% (n = 
  6); Stage III = 7.0% (n = 1); Stage IV = 7.0% 
  (n = 1) 
1999:  
- Prevalence of PIs = 12.0% 
- Stage I = 33.0% (n = 9); Stage II = 63.0% (n = 
  17); Stage III = 4.0% (n = 1); Stage IV = 0%  
- PIs developed in study hospital = 67.0%; PIs 
  developed in other hospitals = 11.0%; PIs 
  developed in the community = 22.0% 
Young (82) 2000 WA A large 
metropolitan 
teaching hospital 
Prospective cohort 
Study period = 6 
weeks 
All consenting people admitted 
to an orthopaedic surgical 
ward at the participating 
hospital 
90 60% - Incidence of PIs = 11.1% (10/90) people 
  developed a PI in the study period 
- Of these PIs: Stage I = 50.0%; Stage II = 50.0% 
Young (67) 2002 WA A large 
metropolitan 
teaching hospital 
Combination of 3 
cross-sectional 
cohort studies 
Study period = 
point prevalence 
at 3 points in 3 
different years 
All people admitted to the 
medical and surgical wards of 
the participating hospital on the 
study days 
1394 70% Of the people included in this study:  
- 15.9% (n = 221) had a PI 
- 22.6% had a PI on admission  
- 12.7% developed a PI while in hospital 
- Median LOS of stay for people with PIs = 34 days, 
  compared with 25 days for all patients 
- 25.0% (n = 20) of long-stay patients (≥91 days 
  admission) had a PI 
First author 
(reference) 
Year State Setting Study type and 
length 
Sample Sample size Quality 
score 
Parameters and findings 
Studies of all leg ulcers (LUs) 
Baker (84) 1994 WA Perth Prospective cross-
sectional 
Study period = 
point prevalence 
All people presenting to a 
general practitioner, medical 
specialist, podiatrist, nursing 
home or community care 
service with a leg ulcer present 
for ≥1 month 
Not 
specified 
80% - Prevalence of LUs = 1.1 per 1000 (0.1%) 
- Prevalence of LUs in ≥60 years = 5.9 per 1000 
- 65.0% of ulcers were recurrent  
Carville (29) 1998 WA Silver Chain 
home care 
service area 
Prospective cross-
sectional 
Study period = 7 
days 
All people attending a 
community nursing service, 
with  a current wound and 
wound care plan, in the study 
week 
Not 
specified 
70% - 817 people had LUs (48.2% of all wounds) 
- Of these, 431/817 (52.7%) were ‘unclassified’ 
- Of these, 73/817 (8.9%) were ‘mixed’ aetiology 
Charles (43) 2014 NSW General 
practitioners 
(GPs) 
participating in 
BEACH study 
Prospective 
longitudinal 
Study period = 1 
year 
All people presenting to a GP 
participating in the BEACH 
study; defined LUs as per the 
International Classification of 
Primary Care (ICPC-2) 
Not 
specified 
50% - Prevalence of LUs = 7 per 1000 patient encounters 
- 59.0% of LUs occurred in people aged ≥75 years  
  = 24 per 1000 patient encounters  
- LUs occurred more frequently in people in 
  residential aged care facilities: 102 per 1000 LU  
  encounters, versus 17 per 1000 total encounters 
Hoskins (31) 1997 NSW Various public 
and private 
community 
healthcare 
providers 
Prospective cohort 
Study period = 3 
months 
All people presenting to one of 
the participating community 
healthcare providers with a leg 
ulcer 
330 60% - Prevalence of LUs = 0.1% 
- Prevalence of LUs in people aged ≥65 years = 0.6% 
- In 3 months, 20.3% (n = 67) of LUs healed 
- Mean duration of LUs = 9.0 years 
Johnson (85) 1995 NSW Sydney Retrospective 
cohort 
All non-institutionalised elderly 
(≥60 years) in the study 
catchment 
1981 = 1050 
1988 = 616 
50% - In 1981, prevalence of LUs = 5/1050 (0.5%) 
- In 1988, prevalence of LUs = 2/616 (0.3%) 
Jopp-McKay (32) 1991 WA Leg ulcer clinic, 
Fremantle 
Hospital, Perth 
Prospective cohort 
Study period = 1 
year 
All people referred to the clinic 116 50% - 38.8% of all LUs were healed at 3 months 
- 67.0% of all LUs were healed at 6 months 
- 10/135 limbs (7.4%) had LUs unhealed at 12 months 
- 16 people (13.8%) with LU complications were  
   admitted to hospital 
Lazzarini (27) 2016a QLD Five public 
hospitals in 
Queensland 
Point prevalence 
survey 
Study period = 1 
selected day 
All people admitted to 
healthcare facilities during the 
study period 
1146 90% Of the people included in this study:  
- 9.8% (n = 72) reported having a previous foot ulcer 
- 6.3% (n = 46) were found to have a current foot ulcer 
Muller (34) 1999 QLD Royal Brisbane 
Hospital ulcer 
clinic 
Prospective cohort 
Study period = 1 
year 
All people presenting to the 
service 
112 40% Of the people included in the study with a wound: 
- Those without complication(s) had an average  
  time to healing of 4.6 weeks 
- Those with one or more complication(s) had an 
  average time to healing of 23.9 weeks; 4.5% (n 
  = 5) were admitted for inpatient care 
Mulligan (61) 2011 WA Hospitals state-
wide 
Prospective cross-
sectional 
Study period = 
point prevalence 
All people admitted to the 
hospital on the days of study 
Not known 90% Of the people included in this study: 
- 2007: 2.6% had a leg ulcer 
- 2008: 2.8% had a leg ulcer 
- 2009: 2.0% had a leg ulcer 
- 2011: 2.3% had a leg ulcer 
Santamaria (35) 2004 WA Clinics in the 
Kimberley region 
Prospective 
randomised 
controlled trial 
Study period = 1 
year 
All people: (1) presenting to 
the service, and (2) with a 
chronic lower extremity ulcer 
Total = 93 
Study = 50 
Control = 43 
80% - For all LUs, healing rate: control = 6.3%  
  per week; intervention = -4.9% per week 
- For all LUs, amputations: control: 6/43 = 14.0%; 
  intervention: 1/50 = 0.02% 
Santamaria (74) 2009 WA Hospitals and 
primary 
healthcare 
services state-
wide 
Prospective cohort 
Study period = 1 
month in 2007; 1 
month in 2008 
All consenting adult, paediatric, 
neonatal inpatients or aged-
care residents admitted in 
public hospitals on audit days 
2007 = 2777 
2008 = 3024 
70% - In 2007, prevalence of LUs = 71/2777 (2.6%) 
- In 2008, prevalence of LUs = 85/3024 (2.8%) 
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TOTAL 
Asimus et al., 
2011 (53) 2 1 0 0 1 0 0 0 1 50% 
Baba et al., 
2014 (38) 1 1 1 0 1 1 1 1 1 80% 
Baba et al., 
2015 (39) 1 1 1 0 1 1 1 1 1 80% 
Bail et al., 2013 
(68) 2 1 1 1 0 1 0 0 1 70% 
Baker et al., 
1991 (21) 1 1 0 0 1 1 1 1 1 70% 
Baker et al., 
1992 (28) 1 1 0 0 1 1 1 1 1 70% 
Banks et al., 
2010 (75) 1 1 1 0 1 1 1 1 1 80% 
Banks et al., 
2016 (25) 0 1 0 0 1 1 1 1 1 60% 
Baker & Stacey, 
1994 (84) 1 1 1 0 1 1 1 1 1 80% 
Barker et al., 
2013 (54) 0 1 0 0 1 1 1 1 1 60% 
Carville & Lewin, 
1998 (29) 1 1 1 1 1 0 0 1 1 70% 
Carville & Smith, 
2004 (30) 1 1 1 0 1 1 0 0 1 60% 
Charles 2014 
(43) 1 1 0 0 1 1 0 0 1 50% 
Charlier, 2001 
(55) 0 1 1 1 1 1 1 1 1 80% 
Clarke et al., 
2008 (40) 2 1 1 1 0 1 0 0 1 70% 
Clinical 
Excellence 
Commission, 
2016 (26) 2 1 1 1 1 0 0 0 1 70% 
Commons et al., 
2015 (95) 0 1 1 0 1 1 0 1 1 60% 
Coyer et al., 
2014 (76) 0 1 0 0 1 0 0 1 1 40% 
Coyer et al., 
2015 (78) 0 1 0 0 1 1 1 1 1 60% 
Coyer et al., 
2016 (24) 2 1 1 1 0 1 0 0 1 70% 
Cubit et al., 
2013 0 1 1 1 1 1 1 1 1 80% 
Davenport, 1999 
(56) 0 1 1 0 0 0 0 1 1 40% 
Davis et al., 
2006 (97) 1 1 1 0 1 1 1 1 1 80% 
Edwards et al., 
2005a (93) 0 1 1 0 1 1 1 1 1 70% 
Edwards et al., 
2005b (101) 0 1 1 0 1 1 1 1 1 70% 
Edwards et al., 
2009 (104) 0 1 1 0 1 0 1 1 1 60% 
Edwards et al., 
2013 (9) 0 1 0 0 1 1 1 1 1 60% 
Elliott et al., 
2008 (70) 0 1 0 0 1 1 1 1 1 60% 
Ellis et al., 2006 
(71) 1 1 1 0 1 1 1 1 1 80% 
Ewald et al., 
2001 (98) 0 1 1 1 0 0 1 1 1 60% 
Finlayson et al., 
2009 (109) 1 1 1 1 0 1 0 1 1 70% 
Finlayson et al., 
2014 (106) 0 1 1 1 1 1 1 1 1 80% 
Gardner et al., 
2009 (63) 0 1 0 0 1 1 1 1 1 60% 
Graves et al., 
2005 (48) 0 1 1 0 0 1 0 0 1 40% 
Haji-Zaine et al., 
2014 (92) 0 1 1 1 0 1 1 1 1 70% 
Hunter et al., 
2014 (57) 0 1 1 0 1 0 0 1 1 50% 
Hoskins et al., 
1997 (31) 1 1 1 0 1 0 0 1 1 60% 
Jackson et al., 
2011 (49) 2 1 1 1 0 0 0 0 1 60% 
Johnson, 1995 
(85) 1 1 0 0 1 0 0 1 1 50% 
Jolley et al., 
2004 (83) 0 1 1 0 1 1 1 1 1 70% 
Jopp-Mckay et 
al., 1991 (32) 0 1 0 0 1 0 1 1 1 50% 
Kapp et al., 
2013 (94) 0 1 1 1 1 1 0 1 1 70% 
Lakhan et al., 
2011 (77) 0 1 0 0 1 1 0 1 1 50% 
Lapsley et al., 
1996 (69) 0 1 0 0 1 1 1 1 1 60% 
Lazzarini et al., 
2013 (42) 2 1 1 1 1 0 0 0 1 70% 
Lazzarini et al., 
2016 (27) 1 1 1 1 1 1 1 1 1 90% 
Lewin et al., 
2003 (80) 1 1 0 0 1 1 1 1 1 70% 
Lewin et al., 
2007 (81) 1 1 0 0 1 1 1 1 1 70% 
Liew et al., 1998 
(33) 0 1 0 0 1 0 1 1 1 50% 
Lim et al., 2006 
(99) 0 1 1 1 0 0 0 1 1 50% 
Madsen et al., 
1997 (73) 0 1 1 1 1 1 1 1 1 80% 
Martin & 
Keenan, 1994 
(58) 0 1 1 0 1 1 1 1 1 70% 
McErlean et al., 
2002 (59) 0 1 1 0 1 1 1 1 1 70% 
McGill et al., 
2005 (88) 0 1 0 0 1 1 1 1 1 60% 
McGowan et al., 
1996 (60) 0 1 1 0 1 1 1 1 1 70% 
McGowan et al., 
2000 (90) 0 1 1 0 1 1 1 1 1 70% 
McRae et al., 
2014 (91) 0 1 1 1 0 0 0 0 1 40% 
McRae et al., 
2016 (23) 0 1 1 0 1 0 0 1 1 50% 
Miles et al., 
2013 (50) 0 1 0 0 1 1 1 1 1 60% 
Morey & Porock, 
1997 (64) 0 1 1 0 1 1 1 1 1 70% 
Muller et al., 
1999 (34) 0 1 1 0 1 0 0 0 1 40% 
Mulligan et al., 
2011 (61) 2 1 1 0 1 1 1 1 1 90% 
O'Brien et al., 
2013 (102) 0 1 0 1 1 0 1 1 1 60% 
O'Rourke et al., 
2002 (96) 0 1 1 1 1 1 1 1 1 80% 
Parker, 2014 
(105) 0 1 0 0 0 1 1 1 1 50% 
Pearson et al., 
2000 (51) 2 1 1 0 1 1 1 1 1 90% 
Perrin et al., 
2006 (41) 0 1 1 1 0 0 0 1 1 50% 
Perrin et al., 
2011 (87) 0 0 0 0 1 0 0 1 1 30% 
Perrin et al., 
2012 (86) 1 0 1 1 1 1 1 1 1 80% 
Prentice, 2007 
(65) 1 1 0 0 1 1 1 1 1 70% 
Quality and 
Safety Branch, 
2006 (66) 2 1 1 0 1 1 1 1 1 90% 
Rayner, 2007 
(36) 0 1 0 0 0 1 0 1 1 40% 
Rodrigues et al., 
2016 (22) 0 1 1 1 0 0 0 0 1 40% 
Roosen et al., 
2010 (52) 0 1 1 0 0 0 0 0 1 30% 
Santamaria et 
al., 2004 (35) 1 1 1 0 1 1 1 1 1 80% 
Santamaria et 
al., 2005 (72) 2 1 0 0 1 1 1 1 1 80% 
Santamaria et 
al., 2009 (74) 2 1 0 1 1 0 0 1 1 70% 
Santamaria et 
al., 2012 (100) 0 1 0 0 1 0 1 1 1 50% 
Smith & 
McGuinness., 
2010 (108) 1 1 0 0 1 0 0 1 1 50% 
Stacey et al., 
1997 (107) 0 1 1 0 1 0 1 1 1 60% 
Tapp et al., 2003 
(89) 2 1 1 0 1 0 0 1 1 70% 
Walker et al., 
2014 (37) 1 1 1 1 0 0 0 1 1 60% 
Webster et al., 
2010 (46) 0 1 1 0 1 1 1 1 1 70% 
Webster et al., 
2011 (44) 0 1 0 0 1 1 1 1 1 60% 
Webster et al., 
2015 (45) 0 1 0 0 1 1 1 1 1 60% 
Weller et al., 
2012 (103) 1 1 1 0 1 0 1 1 1 70% 
Wright & Tiziani, 
1996 (47) 0 1 1 1 1 1 1 1 1 80% 
Young et al., 
2000a (62) 0 1 0 0 1 1 1 1 1 60% 
Young et al., 
2000b (82) 0 1 0 0 1 1 1 1 1 60% 
Young et al., 
2002 (67) 0 1 0 1 1 1 1 1 1 70% 
